phosphorus has been researched along with Chronic Kidney Diseases in 354 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.28) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 15 (4.24) | 29.6817 |
2010's | 238 (67.23) | 24.3611 |
2020's | 100 (28.25) | 2.80 |
Authors | Studies |
---|---|
Astrup, A; Christoffersen, C; Feldt-Rasmussen, B; Hansen, NM; Kamper, AL; Rix, M; Salomo, L | 1 |
Atwal, J; Bakke, AM; Bijsmans, ES; Biourge, VC; Carvell-Miller, LJ; Coltherd, JC; Elliott, D; Elliott, J; Gilham, M; Renfrew, H; Schauf, S; Watson, P | 1 |
How, P; Lee, C; Lim, R; Lo, E; Wong, WK; Yong, XN | 1 |
Chon, Y; Drayer, D; Goodman, WG; Lai, J; Martin, KJ; Moore, C; Nemeth, EF; Ward, DT; Xu, J | 1 |
Furth, SL; Matheson, MB; Schwartz, GJ; Shah, LN; Warady, BA; Wong, CJ | 1 |
Asahi, K; Iwasaki, T; Kazama, JJ; Kazama, S; Kimura, H; Oda, A; Saito, H; Shimabukuro, M; Tanaka, K; Watanabe, S; Watanabe, T | 1 |
Cao, J; Gan, W; Wen, P; Xie, W; Xiong, M; Yang, J; Zhang, L; Zhao, S | 1 |
Fülöp, T; Salim, SA; Zsom, L; Zsom, M | 1 |
Blumenberg, C; Nascimento, GG; Paranhos, LR; Rodrigues, RPCB; Sabino-Silva, R; Siqueira, MF; Siqueira, WL; Vidigal, MTC; Vieira, WA | 1 |
Hashimoto, T; Ito, K; Matsumoto, Y; Nishino, N; Okuda, Y; Susai, H; Yamada, R; Yokoyama, K | 1 |
Li, H; Li, S; Wang, J; Yin, L | 1 |
Andrews, BJ; Cushing, AC; Murphy, RE; Sula, MM; Wilson, EM | 1 |
Liu, Q; Qi, H; Yao, L | 1 |
Griffiths, M; Mager, DR; Picard, K; Razcon-Echeagaray, A; Richard, C | 1 |
Allen, MR; Avin, KG; Biruete, A; Chen, NX; Clinkenbeard, EL; Metzger, CE; Moe, SM; O'Neill, K; Srinivasan, S; Stacy, AJ; Swallow, EA; Vrabec, C | 1 |
Jindal, K; Mager, DR; Picard, K; Richard, C; Senior, PA; Wilmott, A | 1 |
Chen, S; Li, G; Li, Y; Luo, H; Pu, L; Tang, Y; Wang, L; Wang, W; Xia, J; Xiao, Q; Yu, M | 1 |
Bu, R; Gao, J; Han, R; Hao, J; Li, B; Li, G; Liu, H; Liu, Y; Sun, L; Wang, S; Zhao, J; Zhao, L | 1 |
Cao, JY; Chen, SJ; Liu, BC; Liu, ZX; Ni, WJ; Tang, RN; Tang, TT; Wang, LT; Wang, YJ; Zhang, XL; Zhang, YX | 1 |
Goldfarb, DS; Hu, L; Jagannathan, R; Katz, SD; Kharmats, AY; Li, H; Ogedegbe, O; Popp, C; Sevick, MA; St-Jules, DE; Wang, C; Williams, SK; Woolf, K | 1 |
Sun, T; Yu, X | 1 |
Barreto Silva, MI; de Abreu, DBV; Gadas, OM; Klein, MRST; Picard, K; Richard, C | 1 |
Brier, ME; Gaweda, AE; Lederer, ED | 1 |
Ahn, JP; Hwang, J; Kang, WK; Kim, HJ; Moon, SJ | 1 |
Fukui, K; Gao, J; Hashimoto, A; Kanome, Y; Kohno, M; Nakatsu, M; Ogawa, Y | 1 |
Bai, Y; Chen, L; Chen, T; Fan, J; Guo, Y; Han, J; Jin, X; Li, J; Li, X; Liu, L; Liu, Z; Ma, S; Qian, G; Shi, G; Shui, R; Tao, S; Wang, D; Wang, H; Wang, W; Wu, H; Yang, J; Yang, S; Yu, L; Zhang, F; Zhang, Y; Zong, X | 1 |
Güney, İ; Yazıcı, R | 1 |
Gupta, A; Kapoor, V; Sachan, T; Saxena, A | 1 |
Allen, MR; Damrath, JG; Metzger, CE; Wallace, JM | 1 |
Bilbau Sant'Anna, P; Chalfun Guimarães-Okamoto, PT; Ferreira de Souza, F; Melchert, A; Mogollón García, HD; Moreira Dos Santos Schmidt, E; Picelli de Azevedo, MG; Pinheiro Ferreira, JC; Poloni Batista, B; Rezende Dadalto, C; Rodrigues Maia, S; Salgueiro Geraldes, S; Silveira de Moraes, R | 1 |
Adachi, K; Hisada, T; Mochizuki, J; Wakino, S; Watanabe, S | 1 |
Chang, CI; Hsu, CC; Huang, MC; Hung, SC; Lin, TY; Tai, TH | 1 |
Beketov, VD; Milovanova, LY; Milovanova, SY; Taranova, MV; Volkov, AV | 1 |
Abinti, M; Caldiroli, L; Castellano, G; Molinari, P; Rusconi, C; Vettoretti, S | 1 |
Chen, G; Liu, Y; Yang, Q; Zhou, T | 1 |
Goto, M; Horii, Y; Morimoto, N; Nishimura, G; Sato, H; Takahashi, N; Tokushima, H | 1 |
Liu, D; Wang, H | 1 |
Balieiro, JCC; Brunetto, MA; Chacar, FC; Machado, DP; Pfrimer, K; Pontieri, CFF; Ruberti, B; Teixeira, FA; Vendramini, THA | 1 |
Li, M; Li, Y | 1 |
Andrade, JM; Hymes, JL; Jiao, Y; Larkin, JW; Parker, JR; Tibbetts, J | 1 |
Chen, J; Kalantar-Zadeh, K; Wang, M; Zhang, J | 1 |
Dărăban, AM; Elian, V; Karampelas, O; Licu, M; Mititelu, M; Moroșan, E; Popovici, V; Rusu, AI | 1 |
Alonso-Montes, C; Astudillo-Cortés, E; Avello-Llano, N; Calleros, L; Cannata-Andía, JB; Carrillo-López, N; Dusso, AS; Fernández-Villabrille, S; Mariño, G; Martín-Carro, B; Martín-Vírgala, J; Mora-Fernández, C; Navarro-González, JF; Naves-Díaz, M; Panizo, S; Tamargo-Gómez, I | 1 |
Akiyama, S; Doi, N; Harasawa, T; Hasegawa, S; Omi, A; Ono, Y; Shimizu, Y | 1 |
Chen, Y; Hu, N; Xie, Q | 1 |
Burstad, KM; Butler, M; Cladis, DP; Hill Gallant, KM; Wiese, GN | 1 |
Amadeu de Oliveira, F; Andras, NL; Chu, EY; Eltilib, LA; Foster, BL; Kinoshita, Y; Millán, JL; Mohamed, FF; Narisawa, S; Tani, T; Yalamanchili, RR | 1 |
Chen, H; Guo, X; Hu, Y; Li, Y; Liu, X; Liu, Y; Shen, J; Wang, Q | 1 |
Bae, EH; Choi, HS; Hyun, YY; Kim, CS; Kim, SW; Ma, SK; Oh, KH; Oh, TR; Suh, SH; Sung, S | 1 |
Biruete, A; Hill Gallant, KM; Kistler, BM; Lloyd, L; Meade, A; Moe, SM; St-Jules, DE | 1 |
Gao, MZ; Hong, FY; Lin, LP; Lin, M; Liu, WH; Ruan, YP; Wu, SS; Zhang, L | 1 |
Chen, P; Liu, Y; Xie, X; Xu, T; Yang, X; Zhang, X; Zhao, Y; Zhu, X | 1 |
Bellorin-Font, E; Martin, KJ; Vasquez-Rios, G | 1 |
Biruete, A; Chen, NX; Hill Gallant, KM; Lachcik, PJ; Moe, SM; Srinivasan, S; Vorland, CJ | 1 |
Athienites, NV; Coyne, DW; Ficociello, LH; Kalantar-Zadeh, K; Kossmann, RJ; Mullon, C; Parameswaran, V | 1 |
Ahn, C; Han, M; Kang, E; Kim, HJ; Kim, YS; Lee, KB; Oh, KH; Ryu, H; Sung, S | 1 |
Cheng, C; Huang, H; Ma, H; Purrunsing, Y; Ren, W; Wang, J; Wang, N; Xing, C; Yang, G; Ye, Y; Yin, C; Zeng, M; Zhang, L | 1 |
Al-Makki, A; Frost, K; Overholser, B; Shepler, B; Yun, SA | 1 |
Jovanovich, A; Ray, M | 1 |
Aguilera-Tejero, E; Alcalá-Díaz, J; Almadén, Y; Díaz-Tocados, JM; Felsenfeld, A; Herencia, C; López-Baltanás, R; Martínez-Moreno, JM; Montes de Oca, A; Muñoz-Castañeda, JR; Ortiz, A; Pineda, C; Rodríguez, M; Rodríguez-Ortiz, ME | 1 |
Berga, F; Buades, JM; Costa-Bauzá, A; Fortuny, R; Grases, F; Molina, M; Muñoz, E; Sanchis, P | 1 |
Claudino, G; Cuppari, L; Muniz, GAS; Pereira, RA; Ramos, CI; Teixeira, RR | 1 |
Asif, N; Ijaz, A; Khadim, MT; Khan, NB; Memon, AA; Nawaz, MA; Sawal, HA | 1 |
Castellino, P; Fatuzzo, P; Gaudio, A; Granata, A; Lentini, P; Malatino, L; Rapisarda, F; Sessa, C; Xourafa, A; Zanoli, L | 1 |
Duque, EJ; Elias, RM; Moysés, RMA | 1 |
Biruete, A; Hill Gallant, KM; Stremke, ER | 1 |
Auh, JH; Booth, CJ; Cha, JY; Cho, SW; Choi, C; Choi, HJ; Choi, HS; Hur, J; Im, SS; Jung, WJ; Jung, YJ; Jung, YS; Kang, J; Kim, H; Kim, JW; Kim, OH; Kim, YB; Lee, CS; Lee, DH; Lee, J; Lee, YJ; Oh, BC; Park, KS; Park, YJ; Yang, JY | 1 |
Gutiérrez, OM | 1 |
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
Apfelbaum, N; Aroch, I; Chen, H; Dunaevich, A; Kuzi, S; Mazaki-Tovi, M; Segev, G | 1 |
Arakawa, K; Arita, Y; Fukui, A; Imazu, R; Kitazono, T; Matsukuma, Y; Nakano, T; Nakayama, M; Seki, M; Sonoda, Y; Tominaga, M; Tsuda, S; Tsuruya, K; Yoshitomi, R | 1 |
Nakashima, A; Ohkido, I; Okabe, M; Saito, Y; Uchiyama, T; Yokoo, T | 1 |
Chiang, HY; Chu, PL; Huang, HC; Kuo, CC; Ting, IW; Yeh, HC | 1 |
Endo, Y; Fukagawa, M; Hamano, N; Kawata, T | 1 |
Covic, AC; Floege, J; Ketteler, M; Perrin, A; Rastogi, A; Sprague, SM; Walpen, S | 1 |
Bowles, M; Byrne, FN; Connolly, P; Earlie, J; Eustace, J; Gillman, B; Kearney, P; Kiely, M; Murphy, J; Reilly, EO; Rennick, T; Shiely, F | 1 |
Amaral, AR; Brunetto, MA; Duarte, CN; Kogika, MM; Lima, DM; Pedrinelli, V; Porsani, M; Teixeira, FA; Vendramini, THA; Zarif, C | 1 |
Lee, JB; Lee, KP; Oh, YI; Seo, KW; Song, KH; Yi, HJ | 1 |
Oladitan, L; VanSickle, JS | 1 |
Lin, W; Zhong, H; Zhou, T | 1 |
Cha, TL; Chang, TC; Hsu, YJ; Liu, CY; Tsao, CW; Wu, ST | 1 |
Jiang, J; Li, Y; Liu, G; Wang, Z; Zheng, D; Zhou, H | 1 |
Rodríguez, M; Rodríguez-Ortiz, ME | 1 |
Al Salam, S; Al Suleimani, Y; Al Za'abi, M; Ali, BH; Ashique, M; Manoj, P; Nemmar, A | 1 |
Chen, KH; Chen, LR; Hsu, CY | 1 |
Hsieh, YJ; Hsu, BG; Kuo, CH; Lai, YH; Lin, YL; Tsai, JP; Wang, CH | 1 |
Abitbol, CL; Ahn, SY; Balgradean, M; Enoiu, M; Fathallah-Shaykh, S; Fila, M; Greenbaum, LA; Jankauskiene, A; Jeck, N; Klaus, G; Nelson, R; Paredes, A; Perrin, A; Stoica, C; Swinford, RD; Wickman, L | 1 |
Fujimoto, S; Fukuhara, S; Green, J; Ishibashi, Y; Kawarazaki, H; Koitabashi, K; Kurita, N; Shibagaki, Y; Suzuki, T; Wakita, T; Yanagi, M; Yazawa, M | 1 |
Ito, S; Kisu, K; Mitsui, S; Miyazaki, M; Oe, Y; Sato, E; Sato, H; Sekimoto, A; Shibata, N; Takahashi, N | 1 |
Borges, LD; Cavalier, SBO; Cotta, RMM; da Costa, GD; da Silva, LS; da Silva, RG; Dias, HH; Ferreira, ES; Machado, JC; Moreira, TR; Silva, BO | 1 |
Akchurin, O; Biswas, S; Gajjar, A; Kumar, J; Meza, K; Perelstein, E; Zhu, YS | 1 |
Singh, A; Tandon, C; Tandon, S | 1 |
Biourge, V; Chang, YM; Elliott, J; Geddes, RF; Jepson, RE; van den Broek, DHN | 1 |
Chillon, JM; Choukroun, G; Kamel, S; Laville, SM; Liabeuf, S; Massy, ZA | 1 |
Begen, MA; Dogan, S; Okuyan, HM; Terzi, MY; Turgut, FH | 1 |
de Brito Marques, F; Ferreira, JL; Freire, L; Guedes, C; Guerreiro, L; Silva, S; Soares, V | 1 |
Filipska, I; Knysak, M; Stompór, T; Winiarska, A | 1 |
He, D; Li, J; Li, P; Luo, M; Niu, W; Wang, Y; Wu, X; Yan, M; Zhao, W | 1 |
Chertow, GM; Pergola, PE; Rosenbaum, DP; Yang, Y | 1 |
Battaglia, GG; Clementi, A; Garozzo, M; Gullè, CLM; Milone, F | 1 |
Hill Gallant, KM; Vorland, CJ | 1 |
Akihisa, T; Tsuchiya, K | 1 |
Akizawa, T; Fukagawa, M; Ikejiri, K; Kanda, H; Shigematsu, T; Une, Y | 1 |
Mager, DR; Picard, K; Richard, C | 1 |
Calvo, MS; Uribarri, J | 2 |
Duan, S; Huang, Z; Nie, G; Sun, L; Xing, C; Yuan, Y; Zhang, B; Zhang, C; Zhu, H | 1 |
Kuro-O, M | 2 |
Kurian, GA; Ramesh, A; Ravindran, S; Swaminathan, K | 1 |
Joo, KW; Kang, SW; Kim, DK; Kim, NH; Kim, YC; Kim, YL; Kim, YS; Lee, JP; Lim, CS; Park, JY; Yang, CW; Yoo, KD | 1 |
Chew, DJ; Dembek, K; Giovaninni, LH; Harjes, LM; Kogika, MM; Parker, VJ; Toribio, RE; Young, GS | 1 |
Araujo, RM; Barretti, P; Caramori, JCT; Vogt, BP; Watanabe, MT | 1 |
Dobenecker, B; Kienzle, E; Reese, S; Webel, A | 1 |
Chazot, G; Juillard, L; Lemoine, S | 1 |
Benchetrit, S; Einbinder, Y; Golan, E; Zitman-Gal, T | 1 |
Asplin, J; Brecklin, C; Dobre, M; Feldman, H; Hamm, L; Isakova, T; Jaar, B; Khairallah, P; Leonard, M; Miller, E; Rahman, M; Scialla, JJ; Sharma, K; Wang, X; Wolf, M; Yang, W | 1 |
Dittmer, KE; Elder, PA; Perera, KC | 1 |
Elias, RM; Moysés, RMA | 1 |
Bai, Q; Guo, H; Li, Y; Liu, H; Yang, X; Zhang, X | 1 |
Block, G; Chonchol, M; Isakova, T; Jovanovich, A; Miyazaki, M; Smits, G; Stubbs, J | 1 |
Bouchet, JL; Daugas, É; Drueke, T; Fouque, D; Hannedouche, T; Jean, G; London, G; Roth, H | 1 |
Ferreira, HG; Pires, A; Sobrinho, L | 1 |
Delrue, W; Dhondt, A; Eloot, S; Glorieux, G; Roels, S; Schepers, E; Van Biesen, W; Vanholder, R | 1 |
Oehlhof, P; Phillips, S | 1 |
Ando, K; Aoki, J; Hibi, K; Ikari, Y; Kozuma, K; Maruyama, Y; Nasu, K; Otsuka, M; Sato, T; Tanabe, K; Uehara, Y | 1 |
Katsuoka, Y; Ohkido, I; Yamada, A; Yokoo, T; Yokote, S | 1 |
Hu, XJ; Li, JG; Li, Y; Shan, AQ; Xiao, ZS; Zhang, SZ; Zhang, X | 1 |
Fujii, M; Hosojima, M; Kabasawa, H; Kadowaki, M; Kaseda, R; Kondo, H; Kuwahara, S; Miyazaki, S; Obi, Y; Saito, A; Shimada, H; Suzuki, Y; Watanabe, R | 1 |
Kung, WJ; Lee, CH; Lin, CC; Shih, CT | 1 |
Androsova, TV; Gil, AY; Kiyakbaev, GG; Kozlovskaya, LV; Lebedeva, MV; Milovanov, YS; Milovanova, LY; Milovanova, SY; Mukhin, NA; Rogova, IV; Taranova, MV | 1 |
Fouque, D | 1 |
Akiyama, KI; Futaya, M; Matsushita, A; Nagano, N; Nitta, K; Sugiura, H; Teraoka, A; Tsuchiya, K; Usui, N | 1 |
Cai, H; Dou, L; Liu, S; Lu, J; Ni, Z; Qian, J; Zhan, Y; Zhang, W; Zhu, M | 1 |
Biasato, I; Biasibetti, E; Bigliati, M; Bruni, N; Capucchio, MT; Cocca, T; Martello, E | 1 |
Liu, H | 1 |
Cupisti, A; Gallieni, M | 1 |
Hill Gallant, KM; Martin, BR; McCabe, GP; McCabe, LD; Moe, SM; Peacock, M; Stremke, ER; Weaver, CM | 1 |
Chen, D; Jiang, S; Liu, Z; Xiang, H; Zhang, H; Zhang, L; Zhou, M | 1 |
Cholewa, M; Madziarska, K; Radwan-Oczko, M | 1 |
Jolly, S; Kaur, T; Nakhoul, GN; Nally, JV; Rincon-Choles, H; Sekar, A | 1 |
Akizawa, T; Fukagawa, M; Shigematsu, T; Shimazaki, R | 1 |
Benedito Carrera, C; Del Pozo Blanco, O; Fernández Najera, JE; García Maset, R; García Testal, A; Hervás Marín, D; Meléndez-Oliva, E; Molina Aracil, J; Murgui Chiva, M; Olagüe Díaz, P; Pérez-Domínguez, B; Rico Salvador, IS; Royo Maicas, P; Segura-Ortí, E; Torregrosa De Juan, E | 1 |
Hill Gallant, KM; Stremke, ER | 1 |
Chien, KL; Chiu, YL; Hsu, SP; Liu, LC; Peng, YS; Tsai, SM; Tsai, WC; Wu, HY | 1 |
Qiao, X; Su, X; Wang, L; Xu, B; Yan, B | 1 |
García Frías, P; García Gutiérrez, G; Jiménez Villodres, M; Martín Velázquez, M; Pérez López, C; Rioja Villodres, J; Sánchez Chaparro, MÁ; Valdivielso, P | 1 |
Hamdi, T; Moe, OW; Pak, CYC; Pasch, A; Quiñones, H; Sakhaee, K | 1 |
Aguilera-Tejero, E; Rodriguez, M | 1 |
Inoue, D; Maehara, M; Nishizawa, Y; Oikawa, I; Shigematsu, T; Sugimoto, T | 1 |
Clegg, DJ; Hill Gallant, KM | 1 |
Astrup, A; Kamper, AL; Rix, M; Salomo, L; Sloth, JJ; Thomassen, JQ | 1 |
Cao, Y; Hu, S; Jin, H; Mao, Y; Ren, K; Wang, D; Wang, Y; Wei, L; Zhang, R; Zhang, X | 1 |
El Khoury, CF; Fiaccadori, E; Karavetian, M; Kooman, J; Salhab, N | 1 |
Azadbakht, L; Esmaillzadeh, A; Feizi, A; Najafabadi, MM; Rouhani, MH; Surkan, PJ | 1 |
Calvo, MS; Sherman, RA; Uribarri, J | 1 |
Lin, PH; Scialla, JJ | 1 |
Ashfaq, A; Gilbertson, DT; Peng, Y; Roetker, NS; Wetmore, JB | 1 |
Han, M; Li, J; Li, Y; Liao, R; Maharjan, A; Su, B; Sun, S; Wang, L; Xiong, Y | 1 |
Capelli, I; Carugo, S; Cianciolo, G; Ciceri, P; Cozzolino, M; Galassi, A; Mangano, M | 1 |
Abdulazim, DO; El Mahdy, H; Fayed, A; Hamza, W; Salem, MM; Sharaf El Din, UA; Soliman, A | 1 |
Ix, JH; Lau, WL | 1 |
Aronson, D; Dragu, R; Hammerman, H; Kapeliovich, M | 1 |
Dominguez, JR; Ix, JH; Shlipak, MG; Whooley, MA | 1 |
Bhan, I; Thadhani, R | 1 |
Anderson, C; Criqui, MH; Ix, JH; Palomino, HL; Rifkin, DE; Whooley, MA | 1 |
Inaba, M; Ito, A; Nitta, K; Otsubo, S; Satoh, S; Tanaka, M; Tominaga, Y; Yajima, A | 1 |
Chen, SC; Kestenbaum, B; Li, S; McCullough, PA; Mehrotra, R; Norris, K; Peralta, CA; Saab, G; Sachs, M; Shah, A; Whaley-Connell, A | 1 |
Evenepoel, P; Wolf, M | 1 |
M de Francisco, AL; Rodríguez, M | 1 |
Barril-Cuadrado, G; Puchulu, MB; Sánchez-Tomero, JA | 1 |
Bacchetta, J; Cochat, P; Diallo, D; Dubourg, L; Ranchin, B | 1 |
Huang, CL; Moe, OW | 1 |
Chen, N; Chen, X; Li, X; Li, Y; Ren, H; Shen, P; Shi, H; Wang, W; Wu, X; Xie, J; Zhang, W | 1 |
Flynn, J; Okamura, D; Thompson, K; Zhou, L | 1 |
Ito, M; Koshika, M; Kudo, K; Masakane, I; Nishida, H; Nishida, W; Tanida, H; Tomita, Y | 1 |
Haynes, R; Wheeler, DC | 1 |
Bierhals, AJ; Cheng, SC; Dávila-Román, VG; de las Fuentes, L; Dietzen, DJ; Hruska, KA; Ross, W; Rothstein, M; Seifert, ME; Windus, D | 1 |
Wojcicki, JM | 1 |
Ho, LT; Sprague, SM | 1 |
Liu, L; Peck Palmer, OM; Wheeler, S | 1 |
Gromadziński, L; Januszko-Giergielewicz, B; Pruszczyk, P | 1 |
Masajtis-Zagajewska, A; Muras, K; Nowicki, M | 1 |
Feng, L; He, YM; Huo, DM; Liao, YH; Yang, ZH | 1 |
Kimura, K; Oishi, D; Sakurada, T; Shibagaki, Y; Yasuda, T | 1 |
Li, Q; Li, Y; Meng, Y; Zhang, H; Zuo, L | 1 |
Diniz, H; Frazão, JM | 1 |
Tonelli, M | 1 |
Adema, AY; de Borst, MH; Ter Wee, PM; Vervloet, MG | 1 |
Dellanna, F; Dimkovic, N; Locatelli, F; Pontoriero, G; Spasovski, G; Wanner, C | 1 |
Furth, SL; Jüppner, H; Kumar, J; Messinger, S; Portale, AA; Salusky, IB; Schwartz, GJ; Warady, BA; Wesseling-Perry, K; Wolf, M | 1 |
Bonetti, S; Castiglioni, L; Corazzi, V; Doyon, A; Fabi, M; Masetti, R; Mencarelli, F; Montini, G; Pession, A | 1 |
Anderson, AH; Appleby, D; Babineau, DC; Brecklin, C; Drawz, PE; He, J; Kallem, RR; Rahman, M; Soliman, EZ; Xie, D | 1 |
Carrero, JJ; Cozzolino, M | 1 |
Bai, Y; Cui, L; Gao, C; Xu, J; Yu, Q; Zhang, H; Zhang, J | 1 |
Biggar, P; Graf, H; Ketteler, M; Klauser-Braun, R; Kovarik, J; Müller, HW; Seidinger, S; Veres, A | 1 |
Cozzolino, M; Goldsmith, D; Ketteler, M; Khan, S; Martin, KJ; Sharma, A | 1 |
Kendrick, J; Palit, S | 1 |
Agar, BU; Culleton, BF; Leypoldt, JK | 1 |
Benabdellah, N; Bentata, Y; Haddiya, I; Karimi, I; Yacoubi, H | 1 |
Fujii, H; Goto, S; Ito, J; Kono, K; Nakai, K; Nishi, S; Yonekura, Y | 1 |
Bellasi, A; Di Iorio, B; Pota, A; Russo, D; Russo, L | 1 |
Azevedo, VF; Elias, RM; Miranda, CT; Miranda, MP; Teixeira, Mdo C; Teles, F | 1 |
Chong, EM; Covic, AC; Floege, J; Gaillard, S; Ketteler, M; Lisk, LJ; Rastogi, A; Sprague, SM | 1 |
Kong, XL; Li, WB; Wang, ZS; Wei, Y | 1 |
Bożentowicz-Wikarek, M; Chudek, J; Kocełak, P; Mossakowska, M; Olszanecka-Glinianowicz, M; Owczarek, A; Wiecek, A | 1 |
Cazaña-Pérez, V; Domínguez-Pimentel, V; Donate-Correa, J; Martín-Núñez, E; Mora-Fernández, C; Muros-de-Fuentes, M; Navarro-González, JF | 1 |
Cozzolino, M; Fouque, D; Horne, R; Kalantar-Zadeh, K | 1 |
Bushinsky, DA; Wolf, M | 1 |
Clagett-Dame, M; DeLuca, HF; Plowchalk, DR; Plum, LA; Potochoiba, M; Zella, JB | 1 |
Bostom, A; Ix, JH; Rao, M; Steffes, M | 1 |
Copley, JB; Keddad, K; Preston, P; Prié, D; Ureña-Torres, P; Wan, H; Wilde, P | 1 |
Arrigain, S; Nally, JV; Navaneethan, SD; Sakhuja, A; Schold, JD; Sharp, J | 1 |
Gomes-Filho, IS; Guerra, RN; Libério, SA; Lopes, FF; Pereira, AL; Rodrigues, VP; Thomaz, EB | 1 |
Liu, J; Su, J; Tian, F; Zhang, J | 1 |
Akizawa, T; Kameoka, C; Kaneko, Y; Kanoh, H; Origasa, H | 1 |
Maizel, J; Massy, ZA | 1 |
Bencova, V; Cernohorska, B; Gazovic, V; Maris, K; Nemethova, D; Spustova, V; Straussova, Z | 1 |
Messenger, S | 1 |
Giachelli, CM; Paloian, NJ | 1 |
Hou, Y; Liu, J; Shi, Y; Zhao, Y | 1 |
Azzouz, H; Béji, S; El Ati, Z; Fatma, LB; Krid, M; Maiz, HB; Moussa, FB; Rais, L; Smaoui, W; Zitouna, M; Zouaghi, K | 1 |
Andreucci, M; Battaglia, Y; De Gregorio, MG; Di Iorio, BR; Errichiello, C; Imbriaco, M; Morrone, LF; Russo, D; Russo, L | 1 |
Boschiero, L; Fraccarollo, C; Gatti, D; Gesualdo, L; Granata, S; Lupo, A; Tomei, P; Zaza, G | 1 |
Chang, JF; Chen, HY; Feng, YF; Hsu, SP; Pai, MF; Peng, YS; Wu, HY; Yang, JY | 1 |
Guidi, G; Lippi, I; Marchetti, V; Meucci, V; Tognetti, R | 1 |
Farbodara, T; Haghverdi, F; Mortaji, S; Saidi, N; Soltani, P | 1 |
Sun, J; Wang, R; Yang, XW; Zhai, CJ | 1 |
Bell, N; Black, D; Carreras, CW; Charmot, D; Deshpande, D; Dy, E; He, L; Jacobs, JW; Kohler, J; Koo-McCoy, S; Kozuka, K; Labonté, ED; Langsetmo, I; Leadbetter, MR; Lewis, JG; Navre, M; Spencer, AG; Zhong, Z | 1 |
Chen, HC; Chiu, YW; Hung, CC; Hwang, SJ; Kuo, HT; Kuo, MC; Lee, JJ; Lim, LM; Tsai, JC | 1 |
Chase, HS; Hirsch, JS; Mohan, S; Radhakrishnan, J; Rao, MK | 1 |
Armstrong, CL; Asplin, JR; Janda, K; Moe, SM; Moorthi, RN; Ponsler-Sipes, K | 1 |
Fan, X; Feng, JM; Liu, LL; Ma, JF; Ren, C; Sun, L; Sun, W; Sun, YT; Wang, LN; Xu, TH; Yao, L | 1 |
Elder, GJ; Evenepoel, P; Ix, JH; Jamal, SA; Kasiske, BL; Ketteler, M; Lafage-Proust, MH; Leonard, MB; Shroff, R; Thadhani, RI; Tonelli, MA; Wheeler, DC | 1 |
Mason, DL; Phelps, KR; Stote, KS | 1 |
Coe, FL; Ennis, JL; Sprague, SM; Worcester, EM | 1 |
Betriu, A; Fernández, E; Martín, M; Valdivielso, JM; Valls, J | 1 |
Cannata-Andía, JB; Martin, KJ | 1 |
Da, J; Disthabanchong, S; Lv, J; Wang, H; Wang, J; Wolf, M; Xie, X; Zha, Y; Zhang, L | 1 |
Jara, A; Parra E U, D; Pefaur, J; Quintero, N; Ruiz de Arechavaleta, A; Russo, M; Zitko, P | 1 |
Jing, Z; Wei-Jie, Y | 1 |
Bos, WJ; Cannata-Andia, JB; Covic, A; Dionisi, MP; Fernández-Martín, JL; Ferreira, A; Floege, J; Gorriz, JL; Ketteler, M; Locatelli, F; London, G; Martínez-Camblor, P; Rodríguez-García, M; Rodríguez-Puyol, D; Rutkowski, B; Sánchez, JE | 1 |
Fukagawa, M; Kakuta, T; Omata, M | 1 |
Carlson, S; Hamilton-Reeves, JM; Oladitan, L; Taylor, JM | 1 |
Craig, JC; de Berardis, G; Macaskill, P; Palmer, SC; Ruospo, M; Saglimbene, V; Strippoli, GF; Teixeira-Pinto, A; Tonelli, M | 1 |
Chen, HY; Chiu, YL; Hsu, SP; Pai, MF; Peng, YS; Tsai, WC; Tung, KT; Wu, HY; Yang, JY | 1 |
Amiri, FS | 1 |
Gaber, AO; Moore, LW; Nolte, JV; Suki, WN | 1 |
Ito, M; Tanaka, S | 1 |
Dimkovic, N; Hertel, J; Locatelli, F; Spasovski, G; Wanner, C | 1 |
Boeing, H; Buijsse, B; di Giuseppe, R; Dierkes, J; Fritsche, A; Hirche, F; Kaaks, R; Kühn, T; Stangl, GI; Weikert, C | 1 |
Akazawa, M; Kawasaki, T; Kuyama, T; Maeda, Y; Matsuki, H; Matsumoto, Y | 1 |
Lhotta, K; Mündle, M; Sprenger-Mähr, H; Zitt, E | 1 |
Batech, M; Jacobsen, SJ; Kalantar-Zadeh, K; Rhee, CM; Sim, JJ; Streja, E; Tran, L | 1 |
Chen, Y; Li, Z; Liang, X; Shi, W; Xu, L; Zhang, M; Zhang, Y; Zhong, L | 1 |
Egido, J; González Parra, E; Gracia-Iguacel, C; Ortiz, A; Rodríguez-Osorio, L; Rojas-Rivera, J; Zambrano, DP | 1 |
Albines, Z; Arias, M; García-Unzueta, M; Gundin, S; Kislikova, M; Martín de Francisco, ÁL; Piñera, C; Seras, M; Serrano, M | 1 |
Guo, X; Liu, X; Liu, Z; Ma, W; Su, G; Wu, Y; Xu, Y; Yang, Q; Zhang, L; Zou, C | 1 |
Callas, P; de Waal, D; Heaslip, E | 1 |
Kakuta, H; Taniguchi, K | 1 |
Asplin, J; Brecher, ME; Coe, F; Ennis, J; Gillen, D; Rubenstein, A; Worcester, E | 1 |
Cui, QQ; Fu, SS; Fu, X; Liao, XH; Ning, JP | 1 |
Guan, YF; Wang, J; Zhang, XY | 1 |
Dimkovic, N; Locatelli, F; Spasovski, G; Wanner, C | 1 |
Bover, J; Egido, J; Fernández-Giráldez, E; Martínez-Castelao, A; Praga, M; Solozábal, C; Torregrosa, JV | 1 |
Evenepoel, P; Vervloet, MG | 1 |
Acikgoz, SB; Erdem, T; Sipahi, S; Solak, B | 1 |
Beglinger, L; Chan, C; Dixon, BS; Duff, K; Lindsay, R; Lockridge, RS; Oleson, JJ; Paulsen, JS; Rocco, MV; Rodrigue, JR; Stokes, JB; VanBuren, JM | 1 |
Anderson, JL; Bair, TL; Horne, BD; McCubrey, RO; Morris, DR; Muhlestein, JB; Rassa, AC | 1 |
Bellovich, KA; Chen, J; Feldman, HI; Flack, JM; Gupta, J; Gutiérrez, OM; Isakova, T; Kusek, JW; Lash, JP; Nessel, LC; Parsa, A; Scialla, JJ; Sondheimer, JH; Steigerwalt, S; Wolf, M; Wright, JT | 1 |
Dimković, N; Djukanović, L; Djurić, Ž; Knežević, V; Lazarević, T; Ljubenović, S; Marinković, J; Marković, R; Rabrenović, V | 1 |
Brunelli, S; Feng, M; Kalantar-Zadeh, K; Kovesdy, CP; Lau, WL; Obi, Y; Ravel, VA; Rhee, CM; Soohoo, M; Streja, E; Wang, J | 1 |
Dai, H; Degnan, A; Henderson, S; Oladitan, L; Taylor, JM; Warady, BA | 1 |
Al-Sayyari, AA; Aljubori, H; El Baz, T; Jarraya, F; Kabulbayev, K; Kashif, W; Kurpad, R; Nafar, M; Shaheen, FA; Souqiyyeh, MZ; Tuganbekova, S | 1 |
Fujimura, R; Ito, T; Takaori, K; Tomiyama, Y; Wada, A; Yamato, M; Yokobatake, C | 1 |
Hosseini, SA; Mazdeh, MM; Mirbagheri, SA; Norouzi, J; Yadollahpour, A | 1 |
Alonso-Montes, C; Cannata-Andía, JB; Carrillo-López, N; Dusso, AS; Martínez-Salgado, C; Naves, M; Panizo, S; Rodríguez, I; Román-García, P | 1 |
Brazier, M; Brisset, S; Choukroun, G; El Esper, N; Fournier, A; Kamel, S; Lemaire-Hurtel, AS; Lenglet, A; Liabeuf, S; Mansour, J; Mary, A; Massy, ZA; Mentaverri, R | 1 |
David, V; Francis, C | 1 |
Koiwa, F; Terao, A | 1 |
Jiang, GR; Lin, FJ; Wu, P; Xie, Y; Yao, Y; Yu, Y; Zou, J | 1 |
Bai, YH; Chen, T; Jiao, YX; Sun, L; Wang, YR; Wu, L; Zhang, L; Zhu, H | 1 |
Akizawa, T; Fukagawa, M; Koiwa, F; Terao, A; Yokoyama, K | 1 |
Furth, SL; Jüppner, H; Messinger, S; Perwad, F; Portale, AA; Salusky, IB; Warady, BA; Wolf, MS | 1 |
Abajo, M; Arroyo, D; Betriu, À; Del Pino, MD; Fernández, E; Gracia, M; Martínez, I; Valdivielso, JM | 1 |
Alcalde-Rodrigo, M; Galicia-Basart, M; Montoro-Ronsano, JB; Pérez-Ricart, A; Segarra-Medrano, A; Suñé-Negre, JM | 1 |
Wang, F; Wang, JW; Zhang, LX; Zhao, MH; Zhou, C | 1 |
Ali, S; Bishop, CW; Crawford, PW; Lee, S; Mangoo-Karim, R; Melnick, JZ; Petkovich, PM; Sprague, SM; Strugnell, SA | 1 |
Abraham, AG; Betoko, A; Furth, SL; Greenbaum, LA; Hui, WF; Moxey-Mims, MM; Savant, JD; Warady, B | 1 |
Boronat, M; Bosch, E; García-Cantón, C; Lorenzo, D; Riaño, M; Santana, Á | 1 |
Aguirre Arango, JV; Restrepo Valencia, CA | 1 |
Koiwa, F; Taketani, Y; Yokoyama, K | 1 |
Baddoura, W; Botros, Y; Chandran, CB; Chowdhury, DN; DeBari, VA | 1 |
Akiba, T; Akizawa, T; Fujii, A; Fukagawa, M; Kuramoto, T; Odani, M; Shigematsu, T; Yokoyama, K | 1 |
Chew, DJ; Dembek, K; Harjes, LM; Parker, VJ; Toribio, RE; Young, GS | 1 |
Caetano, C; Garagarza, C; Oliveira, T; Ponce, P; Silva, AP; Valente, A | 1 |
Shah, A | 1 |
Bolin, A; Dixon, D; Koch, K; Ma, J; Nakane, M; Noonan, W; Reinhart, G | 1 |
Abitbol, CL; Chandar, J; Freundlich, M; Seeherunvong, W; Zilleruelo, G | 1 |
Eknoyan, G | 1 |
Fukushima, N; Kusano, K; Miyamoto, K; Saito, H; Segawa, H | 1 |
Brazhnikova, VV; Orlova, II; Rodosskaia, NK | 1 |
Ali, N; Chittineni, H; Durie, N; Dutka, P; Fishbane, S; Packman, M | 1 |
Bellasi, A; Brancaccio, D; Cozzolino, M; Galassi, A; Gallieni, M | 1 |
Craig, JC; Elder, GJ; Navaneethan, SD; Palmer, SC; Strippoli, GF | 1 |
Baird, B; Beddhu, S; Cheung, AK; Greene, T; Ma, X | 1 |
Gan, LY; Li, X; Wang, M; Wei, T | 1 |
Short, RA; Tuttle, KR | 1 |
Finch, JL; Lane, N; Nakamura, H; Shahnazari, M; Slatopolsky, E; Tokumoto, M; Yao, W | 1 |
Amer, A; Block, GA; Brillhart, SL; Persky, MS; Slade, AJ | 1 |
Salusky, IB; Zaritsky, JJ | 1 |
Chan, C; Hodsman, A; Jindal, K; Klarenbach, S; Manns, BJ; Mendelssohn, DC; Soroka, SD; Zimmerman, DL | 1 |
Hou, FF; Zhang, X | 1 |
Canziani, ME; Carvalho, AB; Draibe, SA; Higa, A; Tomiyama, C | 1 |
Fox, CS; Hwang, SJ; Melamed, ML; Muntner, P; O'Seaghdha, CM | 1 |
Diaz-Buxo, JA; Greenberg, J; Ho, CH; Kessler, P; Moustafa, M; Qunibi, W; Solomon, R; Winkelmayer, WC | 1 |
Arenas, L; Bover, J; Cannata Andía, J; Caravaca, F; de Francisco, AL; Fernández Giráldez, E; González Parra, E; Lorenzo, V; Martín-Malo, A; Martínez, I; Rodríguez Portillo, M; Torregrosa, JV; Torres, A | 1 |
Ferreira, HG; Pires, A; Raposo, JF; Yokota, H | 1 |
Du, W; Patange, AR; Pettersen, MD; Valentini, RP | 1 |
Awni, WM; Garimella, TS; Klein, CE; Lichtenberger, O; Noertersheuser, PA; Palaparthy, R; Pradhan, RS; Williams, LA | 1 |
Batlle, D; Cases, A; De Alvaro, F; De la Cruz-Troca, JJ; Górriz, JL; Luño, J; Martínez-Castelao, A; Montes, R; Natarajan, A; Navarro-González, JF; Portolés, JM | 1 |
Brunner-Ziegler, S; Fröschl, B; Hiebinger, C; Zsifkovits, J | 1 |
Moe, SM; Moorthi, RN | 1 |
David, V; Gillihan, R; He, N; Hong, Y; Idiculla, A; Liu, S; Quarles, LD; Stubbs, JR | 1 |
Chae, DW; Chin, HJ; Heo, NJ; Kim, S; Lee, H; Na, KY; Oh, SW | 1 |
Coe, F; Ennis, J; Worcester, E | 1 |
Evenepoel, P; Meijers, BK; Vanrenterghem, Y; Viaene, L | 1 |
Bansal, N; Berg, AH; Hsu, CY; Ix, JH; Whooley, M | 1 |
Dickerson, RN | 1 |
Fukushima, S; Hagino, S; Kanasaki, T; Matsumoto, T | 1 |
Barbosa-Leiker, C; McPherson, S; Short, R; Tuttle, KR | 1 |
Isakova, T | 1 |
Akizawa, T; Fukagawa, M; Fukuhara, S; Fukuma, S; Hasegawa, T; Kurokawa, K; Onishi, Y; Yamaguchi, T | 1 |
Chiyotanda, S; Fujimoto, S; Fukudome, K; Kitamura, K; Sato, Y; Toida, T; Yamada, K | 1 |
Jauregui, R; Juarez, R; Musso, CG; Navarro, M; Rivera, H; Vilas, M | 1 |
Calabia-Martínez, J; Clapés-Sánchez, E; Fernández-Real, JM; García-Méndez, I; Guasch-Aragay, B; Martín-Alemany, N; Maté-Benito, G; Sabater-Masdeu, M; Torguet-Escuder, P; Vallès-Prats, M | 1 |
Ando, T; Ito, K; Nagano, N; Yoshitaka, A | 1 |
Kido, S; Nomura, K; Sasaki, S; Segawa, H; Shiozaki, Y; Tatsumi, S | 1 |
Cavalier, E; Cheriet, S; Souberbielle, JC | 1 |
Barrientos, A; Calvo, N; De la Flor, JC; De la Orden, V; Fernández-Pérez, C; Maestro, ML; Pérez-Flores, I; Rafael, S; Sánchez Fructuoso, AI; Valero, R; Valga, F; Veganzones, S; Vidaurreta, M | 1 |
Lafage-Proust, MH; Lessard, M; Mac Way, F | 1 |
Hill, KM; Martin, BR; McCabe, GP; Moe, SM; Peacock, M; Wastney, ME; Weaver, CM | 1 |
Bridges, I; Christiano, C; Cooper, K; Cournoyer, SH; Covic, A; Farouk, M; Kopyt, NP; Rodriguez, M; Ureña-Torres, P; Zehnder, D | 1 |
Kalantar-Zadeh, K; Kovesdy, CP; Li, J; Molnar, MZ; Salusky, I; Sim, JJ; Streja, E; Zaritsky, JJ | 1 |
Chang, PC; Chi, WC; Chuang, HY; Lin, CH; Liu, YC; Wu, YW; Yap, YS | 1 |
Adriaensen, W; Degryse, JM; Gruson, D; Matheï, C; Vaes, B; Van Pottelbergh, G | 1 |
Coronel-Aguilar, D; Fernández-Viña, A; González-Díaz, I; Núñez-Moral, M; Peláez-Requejo, B; Quintana-Fernández, A; Rodríguez-Suárez, C; Sánchez-Álvarez, JE | 1 |
Fujii, H; Goto, S; Kono, K; Maeda, A; Miura, S; Nakai, K; Nishi, S; Takeda, K | 1 |
Chao, MC; Chen, JB; Chen, TH; Hung, KY; Liao, SC | 1 |
Barton, IP; Boonen, S; Burgio, DE; Dunlap, LE; Miller, PD; Roux, C | 1 |
Abe, M; Kobayashi, N; Miyata, S; Nagano, N; Wada, M; Wakita, S; Yamashita, T | 1 |
Anderson, CA; Miller, ER | 1 |
García de Vinuesa, S; Goicoechea, M; Gómez Campderá, F; Luño, J; Verdalles, U | 1 |
SMYTH, FS | 1 |
73 review(s) available for phosphorus and Chronic Kidney Diseases
Article | Year |
---|---|
Estimated Glomerular Filtration Rate in Chronic Kidney Disease: A Critical Review of Estimate-Based Predictions of Individual Outcomes in Kidney Disease.
Topics: Acidosis; Frailty; Glomerular Filtration Rate; Humans; Kidney; Phosphorus; Proteinuria; Renal Dialysis; Renal Insufficiency, Chronic | 2022 |
Salivary changes in chronic kidney disease and in patients undergoing hemodialysis: a systematic review and meta-analysis.
Topics: Calcium; Humans; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2022 |
FGF23 Actions in CKD-MBD and other Organs During CKD.
Topics: Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Humans; Phosphates; Phosphorus; Renal Insufficiency, Chronic | 2023 |
Can Mediterranean Diet Have a Positive Impact on Kidney Health? A Pending Answer to a Long-Time Question.
Topics: Diet; Diet, Mediterranean; Dietary Fiber; Fatty Acids; Humans; Kidney; Micronutrients; Phosphorus; Potassium; Renal Insufficiency, Chronic; Sodium | 2022 |
A Systematic Review and Meta-analysis of Efficacy and Safety of Calcimimetic Agents in the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.
Topics: Calcimimetic Agents; Calcium; Humans; Hyperparathyroidism, Secondary; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic | 2022 |
Focusing on Phosphorus Loads: From Healthy People to Chronic Kidney Disease.
Topics: Bone and Bones; Fibroblast Growth Factors; Humans; Kidney; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2023 |
Effects of Plant-Based Protein Consumption on Kidney Function and Mineral Bone Disorder Outcomes in Adults With Stage 3-5 Chronic Kidney Disease: A Systematic Review.
Topics: Adult; Chronic Kidney Disease-Mineral and Bone Disorder; Dietary Proteins; Humans; Kidney; Kidney Failure, Chronic; Minerals; Parathyroid Hormone; Phosphorus; Plant Proteins; Renal Insufficiency, Chronic | 2023 |
'Phos'tering a Clear Message: The Evolution of Dietary Phosphorus Management in Chronic Kidney Disease.
Topics: Diet; Humans; Hyperphosphatemia; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2023 |
Controversies in the Management of Secondary Hyperparathyroidism in Chronic Kidney Disease.
Topics: Calcimimetic Agents; Chelating Agents; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Vitamin D | 2019 |
Mineral Bone Abnormalities and Vascular Calcifications.
Topics: Animals; Calcium; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Humans; Klotho Proteins; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Vascular Calcification; Vitamin D | 2019 |
Diet in Chronic Kidney Disease: an integrated approach to nutritional therapy.
Topics: Diet; Dietary Proteins; Energy Intake; Feeding Behavior; Humans; Nutrition Therapy; Phosphorus; Potassium; Quality of Life; Renal Insufficiency, Chronic; Sodium | 2020 |
[Vascular dysfunction in Cardiorenal Syndrome type 4].
Topics: Aorta; Arginine; Autonomic Nervous System Diseases; Bone Diseases, Metabolic; Cardio-Renal Syndrome; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Inflammation; Myocardial Infarction; Oxidative Stress; Phosphorus; Renal Insufficiency, Chronic; Toxins, Biological; Tunica Intima; Uric Acid; Vascular Stiffness; Vasculitis | 2020 |
Parathyroid Hormone: A Uremic Toxin.
Topics: Bone and Bones; Bone Remodeling; Calcium; Energy Metabolism; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Uremia | 2020 |
Dietary Protein Intake and Bone Across Stages of Chronic Kidney Disease.
Topics: Amino Acids, Essential; Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, High-Protein; Diet, Protein-Restricted; Diet, Vegetarian; Dietary Proteins; Disease Progression; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Severity of Illness Index | 2020 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Development of evocalcet for unmet needs among calcimimetic agents.
Topics: Calcimimetic Agents; Calcium; Cinacalcet; Gastrointestinal Diseases; Humans; Hyperparathyroidism, Secondary; Japan; Naphthalenes; Phosphorus; Pyrrolidines; Receptors, Calcium-Sensing; Renal Dialysis; Renal Insufficiency, Chronic | 2020 |
Revising Dietary Phosphorus Advice in Chronic Kidney Disease G3-5D.
Topics: Humans; Kidney Failure, Chronic; Phosphates; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2021 |
Current and Emerging Drugs in the Treatment of Anemia in Patients with Chronic Kidney Disease.
Topics: Anemia; Calcium; Humans; Phosphorus; Renal Insufficiency, Chronic; Risk Factors | 2020 |
Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease.
Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Vitamin D | 2020 |
Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
Topics: Biomarkers; Bone and Bones; Calcium; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Fractures, Bone; Humans; Kidney Diseases; Osteoporosis; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D | 2020 |
An update on vascular calcification and potential therapeutics.
Topics: Atherosclerosis; Calcimimetic Agents; Calcium; Denosumab; Diabetes Mellitus; Diphosphonates; Dyslipidemias; Enzyme Inhibitors; Homeostasis; Hypertension; Inositol Phosphates; Phosphorus; Renal Insufficiency, Chronic; Thiosulfates; Vascular Calcification; Vitamin D; Vitamin K | 2021 |
Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins.
Topics: Adsorption; Animals; Bacteria; Carbon; Charcoal; Chelating Agents; Gastrointestinal Microbiome; Humans; Intestines; Oxides; Phosphorus; Renal Insufficiency, Chronic; Toxins, Biological; Treatment Outcome | 2021 |
Dietary Phosphorus as a Marker of Mineral Metabolism and Progression of Diabetic Kidney Disease.
Topics: Biomarkers; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetic Nephropathies; Humans; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2021 |
Intestinal phosphorus absorption: recent findings in translational and clinical research.
Topics: Animals; Humans; Intestinal Absorption; Phosphates; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2021 |
The Importance of Phosphate Control in Chronic Kidney Disease.
Topics: Aging; Animals; Bone and Bones; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Klotho Proteins; Membrane Proteins; Parathyroid Hormone; Phosphates; Phosphorus; Renal Insufficiency, Chronic; Risk Factors; Vascular Calcification | 2021 |
The Impact of Protein Type on Phosphorus Intake, Serum Phosphate Concentrations, and Nutrition Status in Adults with Chronic Kidney Disease: A Critical Review.
Topics: Humans; Hyperphosphatemia; Nutritional Status; Phosphates; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2021 |
Klotho and calciprotein particles as therapeutic targets against accelerated ageing.
Topics: Age Factors; Aging; alpha-2-HS-Glycoprotein; Animals; Calcium Phosphates; Cardiovascular Diseases; Fibroblast Growth Factor-23; Humans; Kidney; Klotho Proteins; Nanoparticles; Phosphorus; Renal Elimination; Renal Insufficiency, Chronic | 2021 |
Comparative Efficacy and Safety of Phosphate Binders in Hyperphosphatemia Patients With Chronic Kidney Disease.
Topics: Bile Acids and Salts; Calcium; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Iron; Iron Compounds; Niacin; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2018 |
Phosphorus binders: The new and the old, and how to choose.
Topics: Chelating Agents; Humans; Hyperphosphatemia; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2018 |
Intestinal Phosphorus Absorption in Chronic Kidney Disease.
Topics: Animals; Bone Density; Bone Diseases; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Humans; Intestinal Absorption; Intestines; Kidney; Malabsorption Syndromes; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic; Vitamin D | 2018 |
Effect of diet protein restriction on progression of chronic kidney disease: A systematic review and meta-analysis.
Topics: Adult; Aged; Cause of Death; Clinical Trials as Topic; Diet, Protein-Restricted; Disease Progression; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Proteinuria; Renal Insufficiency, Chronic; Treatment Outcome | 2018 |
Energy-Dense Diets and Mineral Metabolism in the Context of Chronic Kidney Disease⁻Metabolic Bone Disease (CKD-MBD).
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, High-Fat; Energy Intake; Humans; Kidney; Minerals; Oxidative Stress; Phosphorus; Renal Insufficiency, Chronic; Vascular Calcification | 2018 |
Effects of intradialytic aerobic exercise on hemodialysis patients: a systematic review and meta-analysis.
Topics: C-Reactive Protein; Chelating Agents; Cholecalciferol; Exercise; Hospitalization; Humans; Inflammation; Parathyroid Hormone; Phosphorus; Quality of Life; Renal Dialysis; Renal Insufficiency, Chronic | 2019 |
Dietary Phosphate and the Forgotten Kidney Patient: A Critical Need for FDA Regulatory Action.
Topics: Disease Progression; Fibroblast Growth Factor-23; Humans; Phosphorus; Phosphorus, Dietary; Practice Guidelines as Topic; Renal Insufficiency, Chronic; United States; United States Food and Drug Administration | 2019 |
The role of phosphate-containing medications and low dietary phosphorus-protein ratio in reducing intestinal phosphorus load in patients with chronic kidney disease.
Topics: Humans; Hyperphosphatemia; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2019 |
The Key Role of Phosphate on Vascular Calcification.
Topics: Animals; Apoptosis; Autophagy; Humans; Iron; Myocytes, Smooth Muscle; Phosphates; Phosphorus; Renal Insufficiency, Chronic; Vascular Calcification | 2019 |
Clinical detection, risk factors, and cardiovascular consequences of medial arterial calcification: a pattern of vascular injury associated with aberrant mineral metabolism.
Topics: Atherosclerosis; Cardiovascular Diseases; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Monckeberg Medial Calcific Sclerosis; Phosphorus; Renal Insufficiency, Chronic; Risk Factors; Vascular Calcification | 2013 |
Magnesium - its role in CKD.
Topics: Humans; Magnesium; Phosphorus; Renal Insufficiency, Chronic; Risk Factors; Vascular Calcification | 2013 |
Clinical assessment of phosphorus status, balance and renal handling in normal individuals and in patients with chronic kidney disease.
Topics: Animals; Biomarkers; Homeostasis; Humans; Kidney; Phosphorus; Phosphorus Metabolism Disorders; Predictive Value of Tests; Prognosis; Renal Insufficiency, Chronic | 2013 |
Evaluation of anemia and serum iPTH, calcium, and phosphorus in patients with primary glomerulonephritis.
Topics: Adolescent; Adult; Aged; Anemia; Calcium; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic | 2013 |
Women and CKD-mineral and bone disorder.
Topics: Bone Density; Bone Diseases, Metabolic; Calcinosis; Calcium; Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Male; Phosphorus; Renal Insufficiency, Chronic; Sex Factors | 2013 |
Benefits and harm of niacin and its analog for renal dialysis patients: a systematic review and meta-analysis.
Topics: Flushing; Humans; Lipoproteins, HDL; Niacin; Niacinamide; Phosphorus; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Thrombocytopenia; Vitamin B Complex | 2014 |
The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder.
Topics: Animals; Bone and Bones; Calcium; Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Progression; Feedback, Physiological; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Humans; Iron; Mice; Models, Biological; Osteocytes; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Treatment Outcome; Vitamin D | 2013 |
Dietary and pharmacological modification of fibroblast growth factor-23 in chronic kidney disease.
Topics: Calcium; Calcium, Dietary; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Diet; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Lanthanum; Naphthalenes; Phosphorus; Phosphorus, Dietary; Polyamines; Renal Insufficiency, Chronic; Sevelamer | 2014 |
Nutritional therapy, phosphate control and renal protection.
Topics: Diet; Dietary Proteins; Dietary Supplements; Disease Progression; Humans; Life Style; Malnutrition; Phosphorus; Renal Insufficiency, Chronic; Sodium, Dietary | 2014 |
Vascular calcification in chronic kidney disease: role of disordered mineral metabolism.
Topics: Animals; Calcium; Homeostasis; Humans; Phosphorus; Renal Insufficiency, Chronic; Vascular Calcification | 2014 |
Beneficial effects of selective vitamin D receptor activation by paricalcitol in chronic kidney disease.
Topics: Cardiovascular Diseases; Ergocalciferols; Humans; Hyperparathyroidism; Hypocalcemia; Parathyroid Hormone; Phosphorus; Receptors, Calcitriol; Renal Insufficiency, Chronic; Treatment Outcome; Vitamin D | 2014 |
Balancing nutrition and serum phosphorus in maintenance dialysis.
Topics: Diet, Protein-Restricted; Dietary Proteins; Disease Management; Humans; Male; Middle Aged; Nutrition Therapy; Phosphate-Binding Proteins; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2014 |
The effects of soy protein on chronic kidney disease: a meta-analysis of randomized controlled trials.
Topics: Creatinine; Dietary Proteins; Glycine max; Humans; Kidney; Phosphorus; Renal Insufficiency, Chronic; Soybean Proteins; Triglycerides | 2014 |
[Pleiotropic effects of sevelamer: a model of intestinal tract chelating agent].
Topics: Animals; Bone Remodeling; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Disease Models, Animal; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Hyperphosphatemia; Inflammation; Intestinal Absorption; Lipid Metabolism; Mice; Phosphorus; Phosphorus, Dietary; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Toxins, Biological; Uremia; Uric Acid | 2014 |
A current understanding of vascular calcification in CKD.
Topics: Calcium; Disease Progression; Elastin; Humans; Kidney Failure, Chronic; Muscle, Smooth, Vascular; Phosphorus; Renal Insufficiency, Chronic; Risk Factors; Vascular Calcification | 2014 |
Educational intervention for metabolic bone disease in patients with chronic kidney disease: a systematic review and meta-analysis.
Topics: Biomarkers; Bone Diseases, Metabolic; Calcium; Databases, Factual; Health Knowledge, Attitudes, Practice; Humans; Hyperphosphatemia; Patient Education as Topic; Phosphorus; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Treatment Outcome | 2014 |
Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis.
Topics: Bone Density; Calcium; Calcium Carbonate; Chelating Agents; Humans; Hypercalcemia; Lanthanum; Parathyroid Hormone; Phosphorus; Radiography; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Vascular Calcification | 2015 |
The challenge of controlling phosphorus in chronic kidney disease.
Topics: Fibroblast Growth Factor-23; Humans; Hyperphosphatemia; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2016 |
Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies.
Topics: Cohort Studies; Disease Progression; Humans; Kidney Failure, Chronic; Phosphorus; Prognosis; Renal Insufficiency, Chronic | 2015 |
Effects of soy protein containing isoflavones in patients with chronic kidney disease: A systematic review and meta-analysis.
Topics: Blood Urea Nitrogen; Body Mass Index; Body Weight; C-Reactive Protein; Creatinine; Glomerular Filtration Rate; Humans; Isoflavones; Phosphorus; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Serum Albumin; Soybean Proteins | 2016 |
[Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].
Topics: Arteriosclerosis; Biomarkers; Bone Diseases, Metabolic; Calcium; Cardiovascular Diseases; Disease Progression; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Humans; Klotho Proteins; Parathyroid Hormone; Phosphorus; Prognosis; Renal Insufficiency, Chronic; Vascular Calcification | 2015 |
Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.
Topics: Biomarkers; Calcium; Humans; Mortality; Parathyroid Hormone; Phosphorus; Renal Agents; Renal Insufficiency, Chronic; Treatment Outcome | 2015 |
Contemporary management of phosphorus retention in chronic kidney disease: a review.
Topics: Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2015 |
[Bone and Nutrition. Nutrition care of renal osteodystrophy].
Topics: Bone and Bones; Calcium; Cholecalciferol; Chronic Kidney Disease-Mineral and Bone Disorder; Diphosphonates; Humans; Nutrition Therapy; Nutritional Status; Osteoporosis; Phosphorus; Prognosis; Protein-Energy Malnutrition; Renal Insufficiency, Chronic | 2015 |
Use of sevelamer in chronic kidney disease: beyond phosphorus control.
Topics: Anticholesteremic Agents; Bone and Bones; Calcinosis; Chelating Agents; Endothelium, Vascular; Endotoxins; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glycation End Products, Advanced; Humans; Inflammation; Intestinal Absorption; Minerals; Oxidative Stress; Phosphorus; Renal Insufficiency, Chronic; Sevelamer; Signal Transduction; Uremia; Vascular Diseases | 2015 |
Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
Topics: Acetates; Alkaline Phosphatase; Bone Density; Bone Diseases, Metabolic; Bread; Calcium; Calcium Compounds; Calcium Phosphates; Calcium, Dietary; Dietary Proteins; Fibroblast Growth Factor-23; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Phosphorus; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic | 2015 |
The pleiotropic effects of paricalcitol: Beyond bone-mineral metabolism.
Topics: Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Minerals; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic | 2016 |
Inflammation regulates fibroblast growth factor 23 production.
Topics: Bone and Bones; Disease; Disease Progression; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Humans; Hypertrophy, Left Ventricular; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Iron; Osteoblasts; Osteocytes; Phosphorus; Renal Insufficiency, Chronic; Vitamin D | 2016 |
Management of phosphorus load in CKD patients.
Topics: Animals; Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperphosphatemia; Minerals; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2017 |
Phosphorus and other aspects of CKD-MBD in the conservative management of chronic kidney disease.
Topics: Animals; Bone Diseases; Calcium; Conservative Treatment; Cost-Benefit Analysis; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Renal Replacement Therapy; Treatment Outcome; Vascular Calcification; Vitamin D | 2017 |
Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification.
Topics: Aging; Animals; Calcinosis; Calcium; Coronary Artery Disease; Humans; Phosphorus; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Vascular Diseases; Vitamin D | 2009 |
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Topics: Acetates; Biomarkers; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hypercalcemia; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Research Design; Sevelamer | 2009 |
Ironing out the phosphorus problem.
Topics: Calcium; Calcium Phosphates; Calcium, Dietary; Humans; Hypocalcemia; Kidney Failure, Chronic; Phosphates; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Renal Insufficiency, Chronic; Safety | 2010 |
[Cinacalcet hydrochloride and phosphate metabolism].
Topics: Animals; Calcium; Cinacalcet; Humans; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2012 |
[Information about phosphorus additives and nutritional counseling].
Topics: Food Additives; Humans; Hyperphosphatemia; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Renal Insufficiency, Chronic | 2012 |
Distinctive aspects of laboratory testing to evaluate mineral and bone metabolism in patients with chronic kidney disease.
Topics: Bone and Bones; Calcium; Clinical Laboratory Techniques; Glomerular Filtration Rate; Guidelines as Topic; Humans; Kidney Tubules, Proximal; Laboratories, Hospital; Minerals; Parathyroid Hormone; Phosphorus; Reference Standards; Renal Insufficiency, Chronic | 2012 |
Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials.
Topics: Age Factors; Aged; Aged, 80 and over; Algorithms; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Calcium; Clinical Trials, Phase III as Topic; Creatine; Double-Blind Method; Etidronic Acid; Female; Humans; Kidney Function Tests; Osteoporosis, Postmenopausal; Phosphorus; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Retrospective Studies; Risedronic Acid; Treatment Outcome; Urinary Tract Infections | 2005 |
48 trial(s) available for phosphorus and Chronic Kidney Diseases
Article | Year |
---|---|
Study protocol: long-term effect of the New Nordic Renal Diet on phosphorus and lipid homeostasis in patients with chronic kidney disease, stages 3 and 4: a randomised controlled trial.
Topics: COVID-19; Diet; Female; Homeostasis; Humans; Phosphorus; Pregnancy; Quality of Life; Randomized Controlled Trials as Topic; Referral and Consultation; Renal Insufficiency, Chronic; SARS-CoV-2; Telephone; Treatment Outcome | 2021 |
Impact of High-Flux Hemodialysis on Chronic Inflammation, Antioxidant Capacity, Body Temperature, and Immune Function in Patients with Chronic Renal Failure.
Topics: Antioxidants; Body Temperature; Calcium; Humans; Immunity; Inflammation; Kidney Failure, Chronic; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2022 |
An Evaluation of Alternative Technology-Supported Counseling Approaches to Promote Multiple Lifestyle Behavior Changes in Patients With Type 2 Diabetes and Chronic Kidney Disease.
Topics: Adult; Counseling; Diabetes Mellitus, Type 2; Humans; Life Style; Phosphorus; Renal Insufficiency, Chronic; Sodium; Weight Gain; Weight Loss | 2023 |
[Soy protein as part of a low-protein diet is a new direction in cardio- and nephroprotection in patients with 3B-4 stages of chronic kidney disease: prospective, randomized, controlled clinical study].
Topics: Amino Acids, Essential; Animals; Body Weight; Diet, Protein-Restricted; Female; Phosphorus; Renal Insufficiency, Chronic; Soybean Proteins; Urea | 2022 |
A Pilot Randomized Crossover Trial Assessing the Safety and Short-Term Effects of Walnut Consumption by Patients with Chronic Kidney Disease.
Topics: Aged; Blood Pressure; Cardiovascular Diseases; Cross-Over Studies; Diet; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Inositol Phosphates; Juglans; Male; Nuts; Parathyroid Hormone; Phosphorus; Pilot Projects; Potassium; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors | 2019 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study.
Topics: Adult; Age Factors; Aged; Calcimimetic Agents; Chelating Agents; Drug Combinations; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Sucrose; Vitamin D | 2020 |
Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease.
Topics: Adolescent; Child; Drug Combinations; Ferric Compounds; Humans; Hyperphosphatemia; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Sucrose | 2021 |
A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY).
Topics: Adult; Aged; Chelating Agents; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Fibroblast Growth Factor-23; Humans; Hyperphosphatemia; Isoquinolines; Male; Middle Aged; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Sodium-Hydrogen Exchanger 3; Sulfonamides | 2021 |
Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia.
Topics: Aged; Chelating Agents; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperphosphatemia; Isoquinolines; Male; Medication Adherence; Middle Aged; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Sodium-Hydrogen Exchangers; Sulfonamides | 2021 |
Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.
Topics: Aged; Bile Acids and Salts; Biomarkers; Bone Density; Chelating Agents; Chromatography, Liquid; Coronary Artery Disease; Coronary Vessels; Correlation of Data; Deoxycholic Acid; Female; Humans; Male; Middle Aged; Osteogenesis; Phosphorus; Renal Insufficiency, Chronic; Vascular Calcification | 2018 |
A Randomized, Double-Blind, Crossover Pilot Trial of Rice Endosperm Protein Supplementation in Maintenance Hemodialysis Patients.
Topics: Aged; Cross-Over Studies; Dietary Proteins; Dietary Supplements; Double-Blind Method; Endosperm; Female; Humans; Japan; Male; Middle Aged; Oryza; Phosphorus; Pilot Projects; Potassium; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2017 |
Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients.
Topics: Adult; Aged; Calcimimetic Agents; Calcium; Drug Administration Schedule; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Japan; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Pyrrolidines; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Young Adult | 2019 |
Influence of Physical Exercise on the Dialytic Adequacy Parameters of Patients on Hemodialysis.
Topics: Aged; Aged, 80 and over; Creatinine; Exercise; Female; Humans; Male; Middle Aged; Phosphorus; Potassium; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Urea | 2019 |
Control of metabolic predisposition to cardiovascular complications of chronic kidney disease by effervescent calcium magnesium citrate: a feasibility study.
Topics: Acid-Base Equilibrium; Acidosis; Aged; Bicarbonates; Biomarkers; Calcium Citrate; Cardiovascular Diseases; Citric Acid; Cross-Over Studies; Drug Combinations; Feasibility Studies; Female; Humans; Hydrogen-Ion Concentration; Hyperphosphatemia; Magnesium; Magnesium Compounds; Magnesium Deficiency; Male; Middle Aged; Organometallic Compounds; Parathyroid Hormone; Phosphates; Phosphorus; Renal Insufficiency, Chronic; Texas; Time Factors; Treatment Outcome | 2019 |
Efficacy and safety of once-monthly risedronate in osteoporosis subjects with mild-to-moderate chronic kidney disease: a post hoc subgroup analysis of a phase III trial in Japan.
Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Calcium; Creatinine; Diphosphonates; Double-Blind Method; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Phosphorus; Renal Insufficiency, Chronic; Risedronic Acid; Treatment Outcome | 2019 |
Short-term effect of the New Nordic Renal Diet on phosphorus homoeostasis in chronic kidney disease Stages 3 and 4.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Cross-Over Studies; Diet; Diet, Vegetarian; Dietary Proteins; Female; Fibroblast Growth Factor-23; Homeostasis; Humans; Male; Middle Aged; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic; Young Adult | 2019 |
[Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Drugs, Chinese Herbal; Enema; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Humans; Klotho Proteins; Parathyroid Hormone; Phosphorus; Receptors, Fibroblast Growth Factor; Renal Insufficiency, Chronic; Sweating Sickness; Syndrome | 2018 |
Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Diabetes Complications; Double-Blind Method; Feasibility Studies; Female; Homeostasis; Humans; Lanthanum; Male; Middle Aged; Phosphates; Phosphorus; Phosphorus, Dietary; Pilot Projects; Renal Insufficiency, Chronic; Risk Factors; Treatment Outcome; Vascular Stiffness | 2013 |
Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
Topics: Aged; Biomarkers; Calcium; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet; Down-Regulation; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Renal Insufficiency, Chronic; Severity of Illness Index; Time Factors; Up-Regulation | 2013 |
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Biomarkers; Calcium; Cholesterol; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Young Adult | 2014 |
Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.
Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Ergocalciferols; Female; Fibroblast Growth Factor-23; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2014 |
Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease.
Topics: Adult; Aged; Biomarkers; Contraindications; Diet, Protein-Restricted; Disease Progression; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic; Severity of Illness Index; Vitamin D | 2014 |
Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease.
Topics: Aged; Calcium Carbonate; Cause of Death; Chelating Agents; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification | 2015 |
A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients.
Topics: Adult; Aged; Chelating Agents; Constipation; Diarrhea; Female; Ferric Compounds; Humans; Hyperphosphatemia; Induction Chemotherapy; Maintenance Chemotherapy; Male; Medication Adherence; Middle Aged; Nausea; Patient Dropouts; Peritoneal Dialysis; Phosphorus; Polyamines; Renal Insufficiency, Chronic; Sevelamer | 2014 |
Effect of calcium carbonate combined with calcitonin on hypercalcemia in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Calcium; Calcium Carbonate; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Young Adult | 2014 |
Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal women.
Topics: Animals; Bone Density Conservation Agents; Calcitriol; Calcium; Chromatography, High Pressure Liquid; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Male; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Postmenopause; Rats; Renal Insufficiency, Chronic; Uremia | 2014 |
Effect of niacin on FGF23 concentration in chronic kidney disease.
Topics: Aged; Calcium; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypolipidemic Agents; Indoles; Male; Middle Aged; Niacin; Parathyroid Hormone; Phosphorus; Receptors, Immunologic; Receptors, Prostaglandin; Renal Insufficiency, Chronic | 2014 |
Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Double-Blind Method; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Lanthanum; Male; Middle Aged; Phosphorus; Placebo Effect; Reference Values; Renal Insufficiency, Chronic; Treatment Outcome | 2014 |
Dose-finding study of bixalomer in patients with chronic kidney disease on hemodialysis with hyperphosphatemia: a double-blind, randomized, placebo-controlled and sevelamer hydrochloride-controlled open-label, parallel group study.
Topics: Chelating Agents; Dose-Response Relationship, Drug; Double-Blind Method; Hyperphosphatemia; Japan; Phosphorus; Polyamines; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Treatment Outcome | 2014 |
Effect of raloxifene on parathyroid hormone in osteopenic and osteoporotic postmenopausal women with chronic kidney disease stage 5.
Topics: Administration, Oral; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Raloxifene Hydrochloride; Renal Dialysis; Renal Insufficiency, Chronic | 2014 |
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study.
Topics: Adult; Biomarkers; Bone and Bones; Calcium; Europe; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prognosis; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Survival Rate | 2015 |
Association of dietary phosphate and serum phosphorus concentration by levels of kidney function.
Topics: Adult; Aged; Body Mass Index; Cohort Studies; Contraindications; Cross-Sectional Studies; Dairy Products; Diet; Dietary Supplements; Edible Grain; Female; Food Additives; Food Labeling; Glomerular Filtration Rate; Humans; Kidney; Male; Nutrition Surveys; Obesity, Morbid; Organophosphorus Compounds; Phosphates; Phosphorus; Renal Insufficiency, Chronic; United States | 2015 |
Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia.
Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Calcium; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Glycated Hemoglobin; Humans; Hyperphosphatemia; Lipids; Male; Middle Aged; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Young Adult | 2015 |
Haemodialysis session: the perfect storm for vascular calcification.
Topics: Acid-Base Imbalance; Aged; Aged, 80 and over; Bicarbonates; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Hemodialysis Solutions; Humans; Magnesium; Male; Middle Aged; Osmolar Concentration; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Vascular Calcification | 2015 |
High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification.
Topics: Adult; Aged; Alkaline Phosphatase; Aorta, Abdominal; Calcium; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Gene Expression Regulation; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Radiography, Abdominal; Regression Analysis; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Vascular Calcification | 2015 |
Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia.
Topics: Adult; Aged; Bile Acids and Salts; Cholesterol, LDL; Diarrhea; Female; Glycated Hemoglobin; Hemodialysis Solutions; Humans; Hyperphosphatemia; Male; Middle Aged; Nausea; Peptide Fragments; Phosphates; Phosphorus; Procollagen; Renal Dialysis; Renal Insufficiency, Chronic; Uric Acid; Vomiting | 2016 |
Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study.
Topics: Adult; Aged; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Niacinamide; Phosphorus; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer | 2017 |
Dose-response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study.
Topics: Aged; Biomarkers; Chelating Agents; Dose-Response Relationship, Drug; Double-Blind Method; Down-Regulation; Female; Ferric Compounds; Humans; Hyperphosphatemia; Japan; Male; Middle Aged; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome | 2017 |
Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study.
Topics: Administration, Oral; Aged; Biomarkers; Calcium; Chelating Agents; Drug Administration Schedule; Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Japan; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Sucrose; Tablets; Time Factors; Treatment Outcome | 2017 |
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.
Topics: 24,25-Dihydroxyvitamin D 3; Aged; Calcifediol; Calcium; Creatinine; Delayed-Action Preparations; Double-Blind Method; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Vitamin D; Vitamin D Deficiency; Vitamins | 2016 |
A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialys
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Calcium; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Peptides; Phosphorus; Receptors, Calcium-Sensing; Renal Dialysis; Renal Insufficiency, Chronic; Young Adult | 2017 |
Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.
Topics: Administration, Oral; Adult; Aged; Biomarkers; Bone Density Conservation Agents; Calcium; Creatinine; Double-Blind Method; Ergocalciferols; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Proteinuria; Renal Insufficiency, Chronic; Sample Size; Treatment Outcome; Vitamin D Deficiency | 2009 |
A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease.
Topics: Acetates; Calcium; Calcium Compounds; Chelating Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Intention to Treat Analysis; Male; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic | 2011 |
Exposure-clinical response analysis of paricalcitol in patients with chronic kidney disease (stage 5) on hemodialysis or peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biological Availability; Calcium; Capsules; Double-Blind Method; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Injections; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Young Adult | 2012 |
Effect of lanthanum carbonate vs. calcium carbonate on serum calcium in hemodialysis patients: a crossover study.
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Analysis of Variance; Calcium; Calcium Carbonate; Chelating Agents; Chi-Square Distribution; Cross-Over Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypercalcemia; Hyperphosphatemia; Isoenzymes; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Tartrate-Resistant Acid Phosphatase; Vitamin D | 2012 |
Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease.
Topics: Administration, Oral; Aged; Analysis of Variance; Biomarkers; Calcium; Calcium Carbonate; Chelating Agents; Cross-Over Studies; Feces; Female; Glomerular Filtration Rate; Humans; Indiana; Kidney; Kinetics; Least-Squares Analysis; Male; Middle Aged; Phosphorus; Renal Insufficiency, Chronic; Severity of Illness Index; Treatment Outcome | 2013 |
Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism.
Topics: Adult; Aged; Calcium; Case-Control Studies; Cinacalcet; Cohort Studies; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; International Agencies; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D; Vitamins | 2013 |
234 other study(ies) available for phosphorus and Chronic Kidney Diseases
Article | Year |
---|---|
Clinical progression of cats with early-stage chronic kidney disease fed diets with varying protein and phosphorus contents and calcium to phosphorus ratios.
Topics: Animals; Calcium; Cat Diseases; Cats; Diet, Protein-Restricted; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Phosphorus; Renal Insufficiency, Chronic | 2021 |
Phosphorus Content of Commonly Prescribed Medications Among Patients With Chronic Kidney Disease.
Topics: Cross-Sectional Studies; Humans; Phosphates; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2022 |
Activation of the Calcium Receptor by Calcimimetic Agents Is Preserved Despite Modest Attenuating Effects of Hyperphosphatemia.
Topics: Aged; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Male; Middle Aged; Parathyroid Hormone; Peptides; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies | 2022 |
Low variability of plant protein intake in the CKiD cohort does not demonstrate changes in estimated GFR nor electrolyte balance.
Topics: Bicarbonates; Child; Glomerular Filtration Rate; Humans; Phosphorus; Plant Proteins; Plant Proteins, Dietary; Potassium; Renal Insufficiency, Chronic; Water-Electrolyte Balance | 2022 |
Association between Serum Inorganic Phosphorus Levels and Adverse Outcomes in Chronic Kidney Disease: The Fukushima CKD Cohort Study.
Topics: Cardiovascular Diseases; Cohort Studies; Disease Progression; Humans; Kidney Failure, Chronic; Phosphorus; Renal Insufficiency, Chronic; Risk Factors | 2022 |
A single-center experience of parathyroidectomy in 1500 cases for secondary hyperparathyroidism: a retrospective study.
Topics: Adult; Calcium; China; Female; Humans; Hyperkalemia; Hyperparathyroidism, Secondary; Hypocalcemia; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Postoperative Complications; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies | 2022 |
Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study.
Topics: Ferric Compounds; Ferritins; Humans; Hyperphosphatemia; Iron; Phosphorus; Product Surveillance, Postmarketing; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic | 2022 |
Blood concentration of symmetric dimethylarginine correlates with kidney damage as assessed with a proposed histologic grading system for chronic kidney disease in tigers (Panthera tigris).
Topics: Animals; Biomarkers; Creatinine; Kidney; Phosphorus; Renal Insufficiency, Chronic; Tigers | 2022 |
A long non-coding RNA H19/microRNA-138/TLR3 network is involved in high phosphorus-mediated vascular calcification and chronic kidney disease.
Topics: Animals; Calcium; Cells, Cultured; MicroRNAs; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorus; Rats; Renal Insufficiency, Chronic; RNA, Long Noncoding; Toll-Like Receptor 3; Vascular Calcification | 2022 |
Currently Available Handouts for Low Phosphorus Diets in Chronic Kidney Disease Continue to Restrict Plant Proteins and Minimally Processed Dairy Products.
Topics: Animals; Dairy Products; Diet; Food Additives; Humans; Phosphorus; Phosphorus, Dietary; Plant Proteins; Renal Insufficiency, Chronic | 2023 |
Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.
Topics: Animals; Biomarkers; Chronic Kidney Disease-Mineral and Bone Disorder; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factors; Homeostasis; Iron; Male; Minerals; Parathyroid Hormone; Phosphorus; Rats; Renal Insufficiency, Chronic; Transferrins | 2022 |
Comparison of diet quality tools to assess nutritional adequacy for adults living with kidney disease.
Topics: Adult; Diet; Diet, Mediterranean; Eating; Humans; Longitudinal Studies; Phosphorus; Potassium; Renal Insufficiency, Chronic | 2022 |
Ubiquitin-specific protease 47 is associated with vascular calcification in chronic kidney disease by regulating osteogenic transdifferentiation of vascular smooth muscle cells.
Topics: Animals; Cell Transdifferentiation; Cells, Cultured; Female; Humans; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteogenesis; Phosphorus; Rats; Renal Insufficiency, Chronic; Tandem Mass Spectrometry; Ubiquitin-Specific Proteases; Vascular Calcification | 2022 |
Lanthanum hydroxide inhibits vascular calcification by regulating the HIF-1 pathway.
Topics: Animals; Cardiovascular Diseases; Lanthanum; Phosphorus; Rats; Renal Insufficiency, Chronic; Vascular Calcification | 2022 |
High phosphorus mediated the release of C-X-C motif chemokine ligand 8 in valvular interstitial cells-induced endothelial-to-mesenchymal transition via miR-214/phosphatase and tensin homolog to promote valvular calcification in chronic kidney disease.
Topics: Aortic Valve; Aortic Valve Stenosis; Calcinosis; Cells, Cultured; Chemokines; Humans; Ligands; MicroRNAs; Phosphoric Monoester Hydrolases; Phosphorus; Renal Insufficiency, Chronic; Tensins | 2022 |
Soaking to Reduce Potassium and Phosphorus Content of Foods.
Topics: Animals; Cattle; Diet; Humans; Phosphorus; Potassium; Renal Insufficiency, Chronic; Vegetables; Water | 2023 |
Artificial intelligence-guided precision treatment of chronic kidney disease-mineral bone disorder.
Topics: Artificial Intelligence; Calcium; Humans; Minerals; Parathyroid Hormone; Phosphates; Phosphorus; Renal Insufficiency, Chronic; Vitamin D | 2022 |
Administration of the probiotic Lactiplantibacillus paraplantarum is effective in controlling hyperphosphatemia in 5/6 nephrectomy rat model.
Topics: Animals; Humans; Hyperphosphatemia; Lactobacillus; Nephrectomy; Phosphates; Phosphorus; Probiotics; Rats; Renal Insufficiency, Chronic | 2022 |
Evaluation of cerium oxide as a phosphate binder using 5/6 nephrectomy model rat.
Topics: Animals; Cerium; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Nephrectomy; Phosphates; Phosphorus; Rats; Renal Insufficiency, Chronic | 2022 |
Investigation on maintenance hemodialysis patients with mineral and bone disorder in Anhui province, China.
Topics: Bone Diseases; Calcium; China; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Male; Middle Aged; Minerals; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2023 |
Prevalence and related factors of poor sleep quality in patients with pre-dialysis chronic kidney disease.
Topics: Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Depression; Dialysis; Hemoglobins; Humans; Male; Middle Aged; Phosphorus; Prevalence; Quality of Life; Renal Insufficiency, Chronic; Sleep Quality; Sleep Wake Disorders; Triglycerides; Young Adult | 2022 |
Effect of Dietary Phosphorous Restriction on Fibroblast Growth 2 Factor-23 and sKlotho Levels in Patients with Stages 1-2 Chronic Kidney Disease.
Topics: Animals; Cardiovascular Diseases; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Glomerular Filtration Rate; Hyperphosphatemia; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2022 |
A novel murine model of combined insulin-dependent diabetes and chronic kidney disease has greater skeletal detriments than either disease individually.
Topics: Adenine; Animals; Blood Glucose; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Fractures, Bone; Glycated Hemoglobin; Insulins; Mice; Mice, Inbred C57BL; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Streptozocin | 2022 |
C-reactive protein concentrations are higher in dogs with stage IV chronic kidney disease treated with intermittent hemodialysis.
Topics: Animals; C-Reactive Protein; Creatinine; Dog Diseases; Dogs; Humans; Phosphorus; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Serum Albumin; Urea | 2022 |
Dietary therapy with low protein genmai (brown rice) to improve the gut-kidney axis and reduce CKD progression.
Topics: Antioxidants; Diet; Dietary Fiber; Humans; Kidney; Oryza; Phosphorus; Potassium; Renal Insufficiency, Chronic | 2022 |
Using a Short Food Frequency Questionnaire to Evaluate Macronutrients, Fiber, Phosphorus, Potassium, and Calcium in Adults with Stages 3-5 Chronic Kidney Disease.
Topics: Adult; Calcium; Calcium, Dietary; Diet; Diet Records; Diet Surveys; Dietary Fiber; Energy Intake; Humans; Kidney Failure, Chronic; Nutrients; Phosphorus; Potassium; Renal Insufficiency, Chronic; Reproducibility of Results; Surveys and Questionnaires | 2022 |
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid Hormone; Phosphorus; Rats; Receptors, Calcium-Sensing; Renal Insufficiency; Renal Insufficiency, Chronic; Vascular Calcification | 2023 |
Retrospective case-control study on screening risk factors of antibiotic-associated encephalopathy in patients with chronic kidney disease.
Topics: Albumins; Anti-Bacterial Agents; Brain Diseases; Case-Control Studies; Humans; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Uric Acid | 2022 |
Body Composition of Healthy Cats and Cats with Chronic Kidney Disease Fed on a Dry Diet Low in Phosphorus with Maintenance Protein.
Topics: Animals; Body Composition; Body Weight; Cats; Diet; Phosphorus; Renal Insufficiency, Chronic | 2022 |
Changes and Influencing Factors of Urinary Phosphorus Excretion in Patients with Different Stages of Chronic Kidney Disease.
Topics: Calcifediol; Female; Glomerular Filtration Rate; Humans; Male; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic | 2023 |
High Protein Whole Food Snack and Albumin Outcomes in Patients With Dialysis-Dependent Chronic Kidney Disease.
Topics: Humans; Kidney Failure, Chronic; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Serum Albumin; Snacks | 2023 |
The Impact of Medical Nutrition Intervention on the Management of Hyperphosphatemia in Hemodialysis Patients with Stage 5 Chronic Kidney Disease: A Case Series.
Topics: Adult; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2023 |
Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment.
Topics: Animals; Biomarkers; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factors; Glucuronidase; Humans; Kidney; Klotho Proteins; Mice; Minerals; Osteogenesis; Phosphorus; Renal Insufficiency, Chronic | 2023 |
Optimal Administration of Phosphorus Adsorbents When Using Medical Nutritional Supplements for Tube-fed Patients.
Topics: Enteral Nutrition; Humans; Nutritional Status; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2023 |
Chronic kidney disease-associated pruritus significantly impacts on quality of life of patients on haemodialysis and associates with increased levels of serum calcium and phosphorus.
Topics: Calcium; Humans; Phosphorus; Pruritus; Quality of Life; Renal Dialysis; Renal Insufficiency, Chronic | 2022 |
Dentoalveolar Alterations in an Adenine-Induced Chronic Kidney Disease Mouse Model.
Topics: Adenine; Animals; Chronic Kidney Disease-Mineral and Bone Disorder; Hyperphosphatemia; Mice; Mice, Inbred C57BL; Phosphorus; Renal Insufficiency, Chronic; X-Ray Microtomography | 2023 |
Integrated network pharmacology, transcriptomics, and metabolomics analysis to reveal the mechanism of salt Eucommiae cortex in the treatment of chronic kidney disease mineral bone disorders via the PPARG/AMPK signaling pathway.
Topics: AMP-Activated Protein Kinases; Animals; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Metabolomics; Mice; Minerals; Network Pharmacology; Phosphorus; PPAR gamma; Quality of Life; Renal Insufficiency, Chronic; Signal Transduction; Transcriptome | 2023 |
Urinary Phosphorus Excretion and Cardiovascular Outcomes in Patients with Pre-Dialysis Chronic Kidney Disease: The KNOW-CKD Study.
Topics: Cardiovascular Diseases; Dialysis; Disease Progression; Humans; Phosphorus; Renal Insufficiency, Chronic; Risk Factors | 2023 |
Complications after radiofrequency ablation of hyperparathyroidism secondary to chronic kidney disease.
Topics: Age Distribution; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Phosphorus; Postoperative Complications; Radiofrequency Ablation; Recurrent Laryngeal Nerve Injuries; Renal Insufficiency, Chronic; Renal Replacement Therapy; Retrospective Studies | 2023 |
Vascular, valvular and kidney calcification manifested in mouse models of adenine-induced chronic kidney disease.
Topics: Adenine; Animals; Calcinosis; Calcium; Humans; Kidney; Male; Mice; Mice, Inbred C57BL; Minerals; Nephrocalcinosis; Phosphorus; Renal Insufficiency, Chronic; Vascular Calcification | 2023 |
Kidney Disease Progression Does Not Decrease Intestinal Phosphorus Absorption in a Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.
Topics: Animals; Bone Density; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Progression; Kidney; Parathyroid Hormone; Phosphorus; Rats; Renal Insufficiency, Chronic | 2020 |
Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study.
Topics: Cohort Studies; Creatinine; Dietary Proteins; Drug Combinations; Drug Substitution; Female; Ferric Compounds; Humans; Hypoalbuminemia; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Serum Albumin; Sucrose | 2019 |
Metabolic acidosis is associated with pulse wave velocity in chronic kidney disease: Results from the KNOW-CKD Study.
Topics: Acidosis; Adult; Aged; Ankle Brachial Index; Bicarbonates; Cholesterol; Cross-Sectional Studies; Female; Humans; Korea; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Proteinuria; Pulse Wave Analysis; Renal Insufficiency, Chronic; Serum Albumin; Vascular Stiffness | 2019 |
The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Calcium; Case-Control Studies; Chronic Kidney Disease-Mineral and Bone Disorder; Creatinine; Cross-Sectional Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Glucuronidase; Hepatitis A Virus Cellular Receptor 1; Humans; Kidney Failure, Chronic; Klotho Proteins; Male; Middle Aged; Minerals; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Urea; Vitamin D | 2020 |
Ergocalciferol Versus Cholecalciferol in Non-Dialysis Dependent Chronic Kidney Disease Patients: A Small Retrospective Cohort Study.
Topics: Adolescent; Adult; Aged; Calcium; Cholecalciferol; Cohort Studies; Ergocalciferols; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies; Vitamin D; Young Adult | 2019 |
Inflammation both increases and causes resistance to FGF23 in normal and uremic rats.
Topics: Animals; Calcitriol; Calcium; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Inflammation; Kidney; Male; Phosphorus; Rats, Wistar; Renal Insufficiency; Renal Insufficiency, Chronic; Uremia; Wnt Signaling Pathway | 2020 |
Biochemical spectrum of parathyroid disorders diagnosed at a tertiary care setting.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Calcium; Child; Child, Preschool; Creatinine; Female; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hypoparathyroidism; Infant; Magnesium; Magnesium Deficiency; Male; Middle Aged; Pakistan; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Sex Distribution; Tertiary Care Centers; Vitamin D; Vitamin D Deficiency; Young Adult | 2020 |
High-phytate/low-calcium diet is a risk factor for crystal nephropathies, renal phosphate wasting, and bone loss.
Topics: Animal Feed; Animals; Bone and Bones; Calcium; Calcium, Dietary; Diet; Female; Male; Minerals; Phosphates; Phosphorus; Phytic Acid; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Risk Factors | 2020 |
Fibroblast Growth Factor 23 and the Last Mile.
Topics: Animals; Biomarkers; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Humans; Hyperparathyroidism, Secondary; Kidney; Phosphorus; Renal Agents; Renal Insufficiency, Chronic; Vitamin D | 2020 |
Acute on chronic kidney disease in cats: Etiology, clinical and clinicopathologic findings, prognostic markers, and outcome.
Topics: Acute Kidney Injury; Animals; Cat Diseases; Cats; Creatinine; Female; Hospitalization; Ischemia; Kidney; Male; Phosphorus; Prognosis; Protons; Pyelonephritis; Renal Insufficiency, Chronic; Retrospective Studies; Urea; Ureteral Obstruction | 2020 |
Association of aortic valve calcification with carotid artery lesions and peripheral artery disease in patients with chronic kidney disease: a cross-sectional study.
Topics: Adult; Aged; Aged, 80 and over; Ankle Brachial Index; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Calcium; Carotid Artery Diseases; Cross-Sectional Studies; Echocardiography; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Lansoprazole; Male; Middle Aged; Parathyroid Hormone; Peripheral Arterial Disease; Phosphorus; Renal Insufficiency, Chronic; Vitamin D; Young Adult | 2020 |
Severe chronic kidney disease environment reduced calcium-sensing receptor expression in parathyroid glands of adenine-induced rats even without high phosphorus diet.
Topics: Animals; Diet; Disease Models, Animal; Gene Expression; Hyperparathyroidism, Secondary; Male; Nuclear Proteins; Parathyroid Glands; Phosphorus; Rats; Rats, Wistar; Receptors, Calcitriol; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; RNA, Messenger; Transcription Factors | 2020 |
Joint Longitudinal Low Calcium High Phosphorus Trajectory Associates with Accelerated Progression, Acute Coronary Syndrome and Mortality in Chronic Kidney Disease.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Calcium; Disease Progression; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Prospective Studies; Renal Insufficiency, Chronic; Young Adult | 2020 |
Nutritional and laboratory parameters affect the survival of dogs with chronic kidney disease.
Topics: Animals; Dog Diseases; Dogs; Female; Kaplan-Meier Estimate; Laboratories; Male; Nutritional Status; Phosphorus; Renal Insufficiency, Chronic; Survival Analysis | 2020 |
Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease.
Topics: Animals; Arginine; Blood Urea Nitrogen; Creatinine; Dog Diseases; Dogs; Female; Glucuronidase; Klotho Proteins; Male; Phosphorus; Renal Insufficiency, Chronic | 2020 |
Use of a Phosphorus Points Education Program to Maintain Normal Serum Phosphorus in Pediatric Chronic Kidney Disease: A Case Report.
Topics: Adolescent; Chronic Kidney Disease-Mineral and Bone Disorder; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic | 2021 |
A High Phosphorus Diet Impairs Testicular Function and Spermatogenesis in Male Mice with Chronic Kidney Disease.
Topics: Animals; Diet; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Phosphorus; Renal Insufficiency, Chronic; Semen Analysis; Spermatogenesis; Testis | 2020 |
Fortified phosphorus‑lowering treatment through administration of lanthanum protects against vascular calcification via regulation of FGF23 in chronic kidney disease.
Topics: Animals; Blood Urea Nitrogen; Calcium; Creatinine; Disease Models, Animal; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Protective Agents; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Vascular Calcification | 2020 |
Effects of repeated increasing doses of cisplatin as models of acute kidney injury and chronic kidney disease in rats.
Topics: Acute Kidney Injury; Albuminuria; Animals; Antineoplastic Agents; Caspase 3; Cisplatin; Creatinine; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Acid-Binding Proteins; Indican; Kidney; Male; NF-E2-Related Factor 2; Phosphorus; Rats, Wistar; Renal Insufficiency, Chronic; Urea; Uric Acid | 2021 |
Association of Low Serum l-Carnitine Levels with Aortic Stiffness in Patients with Non-Dialysis Chronic Kidney Disease.
Topics: Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Body Height; Body Mass Index; Body Weight; Calcium; Carnitine; Cholesterol; Cross-Sectional Studies; Fasting; Female; Humans; Logistic Models; Male; Middle Aged; Phosphorus; Renal Insufficiency, Chronic; Triglycerides; Vascular Stiffness | 2020 |
Association between health-related hope and adherence to prescribed treatment in CKD patients: multicenter cross-sectional study.
Topics: Aged; Blood Pressure; Cost of Illness; Cross-Sectional Studies; Female; Hope; Humans; Male; Middle Aged; Patient Compliance; Phosphorus; Potassium; Quality of Life; Renal Dialysis; Renal Insufficiency, Chronic | 2020 |
Lack of Endothelial Nitric Oxide Synthase Accelerates Ectopic Calcification in Uremic Mice Fed an Adenine and High Phosphorus Diet.
Topics: Adenine; Animals; Aorta; Calcinosis; Diet; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nitric Oxide Synthase Type III; Phosphorus; Renal Insufficiency, Chronic; Uremia | 2021 |
Survival and analysis of predictors of mortality in patients undergoing replacement renal therapy: a 20-year cohort.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Proteins; Calcium; Female; Humans; Iron; Kaplan-Meier Estimate; Kidney Failure, Chronic; Leukocyte Count; Male; Middle Aged; Phosphorus; Prognosis; Proportional Hazards Models; Renal Insufficiency, Chronic; Renal Replacement Therapy; Retrospective Studies; Risk Factors; Serum Albumin; Survival Rate | 2020 |
Tumor necrosis factor-alpha is associated with mineral bone disorder and growth impairment in children with chronic kidney disease.
Topics: Alkaline Phosphatase; Biomarkers; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Cross-Sectional Studies; Humans; Inflammation; Minerals; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Insufficiency, Chronic; Tumor Necrosis Factor-alpha | 2021 |
The effect of attenuating dietary phosphate restriction on blood ionized calcium concentrations in cats with chronic kidney disease and ionized hypercalcemia.
Topics: Animals; Calcium; Cat Diseases; Cats; Hypercalcemia; Phosphates; Phosphorus; Renal Insufficiency, Chronic | 2021 |
Association of serum lncRNA H19 expression with inflammatory and oxidative stress markers and routine biochemical parameters in chronic kidney disease.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Ferritins; Glomerular Filtration Rate; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Osteocalcin; Oxidative Stress; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; RNA, Long Noncoding; RNA, Messenger; Tumor Necrosis Factor-alpha; Up-Regulation | 2021 |
Intensive calcium monitoring improves outcomes on hungry bone syndrome in hyperparathyroidism.
Topics: Administration, Intravenous; Adult; Aged; Calcium; Clinical Protocols; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypocalcemia; Longitudinal Studies; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Postoperative Care; Renal Insufficiency, Chronic; Syndrome; Vitamin D | 2021 |
Association of mineral metabolism biomarkers with chronic kidney disease in Chinese adults.
Topics: Aged; Asian People; Biomarkers; Calcium; Female; Humans; Male; Middle Aged; Nomograms; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies | 2021 |
[Phosphorus binders: trigger for intestinal diverticula formation in an ADPKD patient].
Topics: Diverticulum; Humans; Kidney Failure, Chronic; Phosphorus; Polycystic Kidney, Autosomal Dominant; Renal Insufficiency, Chronic | 2021 |
Perspective: Plant-based Whole-Grain Foods for Chronic Kidney Disease: The Phytate-Phosphorus Conundrum.
Topics: Animal Feed; Animals; Diet; Humans; Nuts; Phosphorus; Phytic Acid; Renal Insufficiency, Chronic | 2021 |
Association of urinary calcium and phosphorus excretion with renal disease progression in type 2 diabetes.
Topics: Calcium; Diabetes Mellitus, Type 2; Disease Progression; Glomerular Filtration Rate; Humans; Phosphorus; Prospective Studies; Renal Insufficiency, Chronic; Retrospective Studies | 2021 |
Nicorandil attenuates neuronal mitochondrial dysfunction and oxidative stress associated with murine model of vascular calcification.
Topics: Animals; Aorta; Calcium; Catalase; Drug Administration Schedule; Free Radical Scavengers; Histocompatibility Antigens Class I; Kidney Function Tests; Lipid Peroxidation; Mitochondria; Mitochondrial Diseases; Nicorandil; Oxidative Stress; Phosphorus; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Thiobarbituric Acid Reactive Substances; Vascular Calcification; Vitamin B Complex | 2017 |
Early dialysis initiation does not improve clinical outcomes in elderly end-stage renal disease patients: A multicenter prospective cohort study.
Topics: Aged; Calcium; Female; Glomerular Filtration Rate; Hemoglobins; Humans; Karnofsky Performance Status; Kidney Failure, Chronic; Male; Phosphorus; Propensity Score; Prospective Studies; Quality of Life; Renal Dialysis; Renal Insufficiency, Chronic; Serum Albumin; Survival Rate | 2017 |
Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease.
Topics: Animals; Biomarkers; Calcium; Case-Control Studies; Creatinine; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Male; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Severity of Illness Index | 2017 |
Most consumed processed foods by patients on hemodialysis: Alert for phosphate-containing additives and the phosphate-to-protein ratio.
Topics: Aged; Brazil; Cross-Sectional Studies; Diet; Dietary Proteins; Fast Foods; Female; Food Additives; Food Analysis; Humans; Hyperphosphatemia; Male; Middle Aged; Nitrogen; Nutrition Assessment; Phosphates; Phosphorus; Phosphorus, Dietary; Proteins; Renal Dialysis; Renal Insufficiency, Chronic; Surveys and Questionnaires | 2016 |
Effect of a high phosphorus diet on indicators of renal health in cats.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Body Weight; Cats; Diet; Feces; Kidney; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2018 |
[Modelling of phosphorus transfers during haemodialysis].
Topics: Animals; Biomarkers; Humans; Hyperphosphatemia; Magnetic Resonance Spectroscopy; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2017 |
Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Urea Nitrogen; Calcium; Female; Glomerular Filtration Rate; Humans; Immunoassay; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Reagent Kits, Diagnostic; Renal Insufficiency, Chronic; Severity of Illness Index; Vitamin D | 2017 |
Acid Load and Phosphorus Homeostasis in CKD.
Topics: Acid-Base Equilibrium; Bicarbonates; Calcium; Cross-Sectional Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic | 2017 |
Serum fibroblast growth factor 23 concentrations in dogs with chronic kidney disease.
Topics: Animals; Calcium; Dog Diseases; Dogs; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Male; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic | 2017 |
Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.
Topics: Age Factors; Aged; Aged, 80 and over; Calcium; Cross-Sectional Studies; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prevalence; Protective Factors; Renal Insufficiency, Chronic; Risk Factors; Sodium Chloride Symporter Inhibitors; Vitamin D | 2017 |
[Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
Topics: Aged; Aged, 80 and over; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Female; France; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Surveys and Questionnaires; Vitamin D | 2017 |
The Calcium/Phosphorus Homeostasis in Chronic Kidney Disease: From Clinical Epidemiology to Pathophysiology.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcium; Female; Homeostasis; Humans; Male; Middle Aged; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies; Young Adult | 2017 |
Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Arginine; beta 2-Microglobulin; Creatinine; Female; Hemodialysis Solutions; Hippurates; Humans; Indican; Male; Middle Aged; Observer Variation; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Toxins, Biological; Urea; Uric Acid | 2017 |
Kidney-Friendly Protein Choices.
Topics: Adult; Dietary Proteins; Energy Intake; Humans; Nutritional Requirements; Patient Education as Topic; Phosphorus; Proteinuria; Renal Insufficiency, Chronic | 2017 |
Impact of Serum Phosphorus Levels on Outcomes After Implantation of Drug-Eluting Stents in Patients on Hemodialysis.
Topics: Aged; Antineoplastic Agents; Cardiovascular Diseases; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Paclitaxel; Phosphorus; Registries; Renal Dialysis; Renal Insufficiency, Chronic; Sirolimus; Treatment Outcome | 2018 |
Effect of adipose-derived mesenchymal stem cell transplantation on vascular calcification in rats with adenine-induced kidney disease.
Topics: Adenine; Adipocytes; Animals; Calcium; Cell- and Tissue-Based Therapy; Kidney; Male; Mesenchymal Stem Cell Transplantation; Phosphorus; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Vascular Calcification | 2017 |
Total parathyroidectomy with forearm auto-transplantation improves the quality of life and reduces the recurrence of secondary hyperparathyroidism in chronic kidney disease patients.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Combined Modality Therapy; Female; Follow-Up Studies; Forearm; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Quality of Life; Recurrence; Renal Insufficiency, Chronic; Transplantation, Autologous; Treatment Outcome; Young Adult | 2017 |
The Divalent Elements Changes in Early Stages of Chronic Kidney Disease.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Copper; Disease Progression; Female; Glomerular Filtration Rate; Humans; Iron; Magnesium; Male; Middle Aged; Phosphorus; Renal Insufficiency, Chronic; Trace Elements; Zinc | 2018 |
[Decreased Serum Levels of Klotho Protein in Chronic Kidney Disease Patients: Clinical Imortance].
Topics: Adult; Biomarkers; Cardiovascular Diseases; Cohort Studies; Disease Progression; Female; Glomerular Filtration Rate; Glucuronidase; Humans; Klotho Proteins; Male; Middle Aged; Parathyroid Hormone; Patient Acuity; Phosphorus; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Russia; Statistics as Topic | 2016 |
Topics: Adipocytes; Diet, Protein-Restricted; Dietary Proteins; Disease Management; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Forecasting; Gastrointestinal Microbiome; Humans; Insulin Resistance; Malnutrition; Nutritional Status; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Toxins, Biological | 2017 |
Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model.
Topics: Animals; Calcitriol; Cell Line; Disease Models, Animal; Doxorubicin; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney; Nephrectomy; Osteopontin; Phosphorus; Rats, Sprague-Dawley; Rats, Wistar; Renal Insufficiency, Chronic; RNA, Messenger; Transforming Growth Factor beta1; Up-Regulation | 2018 |
Variability of serum phosphorus and its association with mortality among hemodialysis patients
.
Topics: Aged; Aged, 80 and over; China; Female; Humans; Male; Middle Aged; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors | 2018 |
A long term feed supplementation based on phosphate binders in Feline Chronic Kidney Disease.
Topics: Animal Feed; Animals; Bicarbonates; Cat Diseases; Cats; Dietary Supplements; Phosphorus; Renal Insufficiency, Chronic; Surveys and Questionnaires; Treatment Outcome | 2018 |
[Correlation of fibroblast growth factor 23 with
adverse prognosis of chronic kidney disease and
therapy strategy].
Topics: Cardiomegaly; Disease Progression; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Phosphorus; Prognosis; Renal Insufficiency, Chronic; Vascular Calcification; Vitamin D; Vitamin D Deficiency | 2018 |
Urinary Phosphorus Excretion: Not What We Have Believed It to Be?
Topics: Biomarkers; Diet; Humans; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2018 |
Twenty-Four-Hour Urine Phosphorus as a Biomarker of Dietary Phosphorus Intake and Absorption in CKD: A Secondary Analysis from a Controlled Diet Balance Study.
Topics: Biomarkers; Diet Therapy; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2018 |
Phosphorus is an independent risk factor for the progression of diabetic nephropathy.
Topics: Biomarkers; Diabetic Nephropathies; Disease Progression; Humans; Kidney; Kidney Failure, Chronic; Phosphorus; Renal Insufficiency, Chronic; Risk Factors | 2018 |
The association between periodontal conditions, inflammation, nutritional status and calcium-phosphate metabolism disorders in hemodialysis patients.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; C-Reactive Protein; Calcium; Calcium Metabolism Disorders; Dental Plaque Index; Female; Gingivitis; Humans; Male; Middle Aged; Nutritional Status; Oral Hygiene; Parathyroid Hormone; Periodontal Index; Periodontitis; Phosphorus; Phosphorus Metabolism Disorders; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Serum Albumin; Severity of Illness Index | 2018 |
Accuracy of a Nutrient Database in Estimating the Dietary Phosphorus-to-Protein Ratio and Using a Boiling Method in Low-Phosphate Hospital Diets.
Topics: Cooking; Databases as Topic; Diet; Dietary Proteins; Food Analysis; Food, Formulated; Hospitals; Humans; Hyperphosphatemia; Meals; Nutrients; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Taiwan | 2018 |
Fractional excretion of phosphorus and vascular calcification in stage 3 chronic kidney disease.
Topics: Aged; Cross-Sectional Studies; Female; Fibroblast Growth Factor-23; Humans; Male; Middle Aged; Phosphorus; Renal Insufficiency, Chronic; Vascular Calcification | 2019 |
Plant-Based Diets in CKD.
Topics: Diet, Vegetarian; Humans; Phosphorus; Potassium; Renal Insufficiency, Chronic | 2019 |
Dietary inflammatory index and its association with renal function and progression of chronic kidney disease.
Topics: Adult; Aged; Blood Urea Nitrogen; Calcium; Creatinine; Cross-Sectional Studies; Diet; Disease Progression; Edible Grain; Female; Fruit; Glomerular Filtration Rate; Humans; Inflammation; Male; Middle Aged; Odds Ratio; Phosphorus; Potassium; Renal Insufficiency, Chronic; Surveys and Questionnaires; Vegetables | 2019 |
Revamping the 'renal' diet: using foods to control phosphorus physiology.
Topics: Diet; Homeostasis; Humans; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2019 |
Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters.
Topics: Adolescent; Adult; Aftercare; Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Blood Chemical Analysis; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Guideline Adherence; Humans; Male; Medicare; Middle Aged; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Insufficiency, Chronic; United States; Vitamin D; Young Adult | 2019 |
Intraoperative Arterial Biopsy in Incident Hemodialysis Patients: Differences Observed.
Topics: Adult; Biopsy; Cohort Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Tunica Intima; Tunica Media; Vascular Calcification | 2019 |
The relation between serum phosphorus levels and clinical outcomes after acute myocardial infarction.
Topics: Aged; Cause of Death; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Myocardial Infarction; Phosphorus; Prognosis; Proportional Hazards Models; Renal Insufficiency, Chronic | 2013 |
Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypophosphatemia, Familial; Male; Middle Aged; Phosphorus; Prognosis; Renal Insufficiency, Chronic; Risk Factors | 2013 |
Fibroblast growth factor-23 and outcomes: new answers, new questions.
Topics: Cardiovascular Diseases; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypophosphatemia, Familial; Male; Phosphorus; Renal Insufficiency, Chronic | 2013 |
24-hour urine phosphorus excretion and mortality and cardiovascular events.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Chi-Square Distribution; Circadian Rhythm; Disease Progression; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney; Linear Models; Male; Middle Aged; Phosphorus; Predictive Value of Tests; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Factors; San Francisco; Time Factors | 2013 |
Impact of lanthanum carbonate on cortical bone in dialysis patients with adynamic bone disease.
Topics: Aged; Bone and Bones; Bone Diseases; Dose-Response Relationship, Drug; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2013 |
No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Disease Progression; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Time Factors | 2013 |
A balanced view of calcium and phosphate homeostasis in chronic kidney disease.
Topics: Calcium; Calcium Carbonate; Chelating Agents; Female; Humans; Kidney; Male; Phosphorus; Renal Insufficiency, Chronic | 2013 |
Table showing dietary phosphorus/protein ratio for the Spanish population. Usefulness in chronic kidney disease.
Topics: Diet; Food; Humans; Phosphorus; Phosphorus, Dietary; Proteins; Renal Insufficiency, Chronic; Spain | 2013 |
[Relationship between glomerular filtration rate, uric acid, and parathyroid hormone in children].
Topics: Adolescent; Albuminuria; Blood Pressure; Body Mass Index; Calcium; Child; Child, Preschool; Creatinine; Female; Glomerular Filtration Rate; Humans; Inulin; Male; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies; Uric Acid | 2013 |
Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.
Topics: Bicarbonates; Blood Urea Nitrogen; Calcium; Chlorides; Creatinine; Endpoint Determination; Humans; Hyperkalemia; Infant; Infant Formula; Magnesium; Milk, Human; Phosphorus; Polystyrenes; Potassium; Renal Insufficiency, Chronic; Retrospective Studies; Sodium; United States | 2013 |
Chronic hemodialysis patients without marked elevation of intact parathyroid hormone are also good candidates for early intervention with cinacalcet.
Topics: Adult; Aged; Algorithms; Bone Diseases, Metabolic; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Sterols; Time Factors; Vitamin D | 2013 |
Chronic kidney disease: Does serum phosphate predict death and ESRD in CKD patients?
Topics: Female; Humans; Kidney Failure, Chronic; Male; Phosphorus; Renal Insufficiency, Chronic | 2013 |
Hyperphosphatemia is associated with anemia in adults without chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES): 2005-2010.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Anemia; Biomarkers; Causality; Comorbidity; Female; Health Care Surveys; Humans; Hyperphosphatemia; Male; Middle Aged; Obesity; Phosphorus; Renal Insufficiency, Chronic; Risk Factors; Sex Distribution; Socioeconomic Factors; Statistics as Topic; United States; Young Adult | 2013 |
Puzzling phosphorus: unlikely results.
Topics: Ascites; Female; Heart Failure; Humans; Hypertension; Middle Aged; Phosphorus; Renal Insufficiency, Chronic; Thrombocytopenia | 2013 |
Hypocalcemia is related to left ventricular diastolic dysfunction in patients with chronic kidney disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Calcium; Diastole; Echocardiography; Female; Forecasting; Heart Failure; Humans; Hypocalcemia; Logistic Models; Male; Middle Aged; Phosphorus; Renal Insufficiency, Chronic; ROC Curve; Ventricular Dysfunction, Left; Ventricular Function, Left | 2014 |
Dietary phosphorus excess: a risk factor in chronic bone, kidney, and cardiovascular disease?
Topics: Biomarkers; Bone Diseases, Metabolic; Cardiovascular Diseases; Chronic Disease; Congresses as Topic; Diet; Evidence-Based Medicine; Fast Foods; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Food Additives; Humans; Nutritional Sciences; Phosphorus; Renal Insufficiency, Chronic; Risk Factors; Societies, Scientific; United States | 2013 |
Efficacy of oral powder compared with chewable tablets for lanthanum carbonate administration in hemodialysis patients.
Topics: Administration, Oral; Aged; Calcium; Female; Humans; Lanthanum; Male; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Tablets; Treatment Outcome | 2013 |
Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Topics: Animals; Aorta; Body Weight; Bone Density; Chronic Kidney Disease-Mineral and Bone Disorder; Densitometry; Disease Models, Animal; Femur; Heparin; Male; Phosphorus; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Vascular Calcification | 2014 |
Serum phosphorus in people with chronic kidney disease: you are what you eat.
Topics: Cardiovascular Diseases; Chelating Agents; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2013 |
Disordered FGF23 and mineral metabolism in children with CKD.
Topics: Adolescent; Age Factors; Biomarkers; Calcium; Canada; Child; Child, Preschool; Creatinine; Cross-Sectional Studies; Cystatin C; Early Diagnosis; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Infant; Kidney; Parathyroid Hormone; Phosphorus; Predictive Value of Tests; Renal Insufficiency, Chronic; Severity of Illness Index; United States; Vitamin D; Vitamin D Deficiency | 2014 |
Calciprotein particle (CPP): a true culprit of phosphorus woes?
Topics: alpha-2-HS-Glycoprotein; Calcium Phosphates; Crystallization; Humans; Hyperphosphatemia; Nanoparticles; Phosphorus; Phosphorus, Dietary; Protein Binding; Renal Insufficiency, Chronic | 2014 |
Left ventricular mass and cardiac function in a population of children with chronic kidney disease.
Topics: Adolescent; Calcium; Child; Child, Preschool; Female; Glomerular Filtration Rate; Heart; Heart Function Tests; Humans; Hypertrophy, Left Ventricular; Male; Phosphorus; Renal Insufficiency, Chronic; Risk Factors; Ultrasonography, Doppler | 2014 |
Heart rate variability is a predictor of mortality in chronic kidney disease: a report from the CRIC Study.
Topics: Adult; Aged; Cardiovascular Diseases; Cohort Studies; Disease-Free Survival; Electrocardiography; Exercise; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Hemoglobins; Humans; Linear Models; Male; Middle Aged; Phosphorus; Renal Insufficiency; Renal Insufficiency, Chronic; Risk Factors; Treatment Outcome; Young Adult | 2013 |
Analysis of a single hemodialysis on phosphate removal of the internal fistula patients by mathematical and statistical methods.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fistula; Humans; Male; Middle Aged; Models, Statistical; Multivariate Analysis; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Treatment Outcome | 2013 |
Paricalcitol treatment of secondary hyperparathyroidism in hemodialysis patients: a German-Austrian, single-arm, open-label, prospective, noninterventional, observational study.
Topics: Aged; Alkaline Phosphatase; Austria; Bone Density Conservation Agents; Calcimimetic Agents; Calcium; Cinacalcet; Ergocalciferols; Female; Germany; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic | 2014 |
Simplified phosphorus kinetic modeling: predicting changes in predialysis serum phosphorus concentration after altering the hemodialysis prescription.
Topics: Drug Prescriptions; Hemodialysis Solutions; Humans; Kinetics; Models, Biological; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Tissue Distribution | 2014 |
[Phospho-calcic status in chronic hemodialysis in Oriental Morocco: assessment of adherence to K/DOQI and KDIGO recommendations].
Topics: Adult; Aged; Calcium; Female; Guideline Adherence; Health Status; Humans; Longitudinal Studies; Male; Middle Aged; Morocco; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Renal Insufficiency, Chronic | 2013 |
Depression in hemodialysis patients: the role of dialysis shift.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Depression; Female; Hemoglobins; Humans; Male; Middle Aged; Phosphorus; Psychometrics; Quality of Life; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Rural Population; Sleep Wake Disorders; Socioeconomic Factors; Surveys and Questionnaires; Time Factors | 2014 |
Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.
Topics: Aged; Aged, 80 and over; Biomarkers; Disease Progression; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic | 2014 |
The pursuit of truth and beauty.
Topics: Bone and Bones; Calcium; Humans; Magnesium; Minerals; Nephrolithiasis; Phosphorus; Renal Insufficiency, Chronic; Sodium | 2014 |
Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Calcium; Chelating Agents; Chi-Square Distribution; Drug Utilization Review; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Phosphates; Phosphorus; Practice Patterns, Physicians'; Propensity Score; Proportional Hazards Models; Registries; Renal Insufficiency, Chronic; Severity of Illness Index; Treatment Outcome | 2014 |
Periodontal status and serum biomarkers levels in haemodialysis patients.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Calcium; Creatinine; Cross-Sectional Studies; Dental Plaque Index; Female; Ferritins; Gingival Hemorrhage; Hemoglobins; Humans; Hyperphosphatemia; Hypoalbuminemia; Iron; Male; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Phosphorus; Potassium; Renal Dialysis; Renal Insufficiency, Chronic; Serum Albumin; Transferrin | 2014 |
Comparison of iPTH values in serum and plasma samples depending on the time and temperature in patients with chronic kidney disease.
Topics: Biomarkers; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Parathyroid Hormone; Phosphorus; Plasma; Renal Insufficiency, Chronic; Serum; Specimen Handling; Temperature | 2014 |
Evaluation of a mineral metabolism protocol in peritoneal dialysis patients.
Topics: Aged; British Columbia; Calcium; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Minerals; Nutritional Status; Nutritional Support; Nutritionists; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies; Serum Albumin | 2014 |
Subcutis calcinosis caused by injection of calcium-containing heparin in a chronic kidney injury patient.
Topics: Aged, 80 and over; Anticoagulants; Biomarkers; Biopsy; Calcinosis; Calciphylaxis; Calcium; Female; Heparin; Humans; Injections, Subcutaneous; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Skin Diseases | 2014 |
Impact of BMI on cardiovascular events, renal function, and coronary artery calcification.
Topics: Adult; Aged; Body Mass Index; C-Reactive Protein; Calcium; Cholesterol, LDL; Cohort Studies; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus; Disease Progression; Female; Glomerular Filtration Rate; Hemoglobins; Humans; Hypertension; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Proteinuria; Renal Dialysis; Renal Insufficiency, Chronic; Serum Albumin; Time Factors; Vascular Calcification | 2014 |
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients.
Topics: Adaptor Proteins, Signal Transducing; Bone Morphogenetic Proteins; Female; Genetic Markers; Humans; Intercellular Signaling Peptides and Proteins; Kidney Transplantation; Matched-Pair Analysis; Middle Aged; Phosphorus; Postmenopause; Renal Insufficiency, Chronic; Transplant Recipients | 2014 |
Combined alkaline phosphatase and phosphorus levels as a predictor of mortality in maintenance hemodialysis patients.
Topics: Alkaline Phosphatase; Biomarkers; Blood Urea Nitrogen; Cholesterol; Creatinine; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Risk Assessment; Serum Albumin; Taiwan | 2014 |
Prognostic role of the product of serum calcium and phosphorus concentrations in dogs with chronic kidney disease: 31 cases (2008-2010).
Topics: Animals; Biomarkers; Calcium; Case-Control Studies; Dog Diseases; Dogs; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies | 2014 |
Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD.
Topics: Animals; Calcinosis; Disease Models, Animal; Gastrointestinal Tract; Isoquinolines; Male; Phosphorus; Random Allocation; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Sodium; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sulfonamides | 2015 |
Low serum calcium is associated with poor renal outcomes in chronic kidney disease stages 3-4 patients.
Topics: Aged; Calcium; Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetes Mellitus; Female; Humans; Hypertrophy, Left Ventricular; Hypocalcemia; Male; Middle Aged; Obesity; Phosphorus; Proportional Hazards Models; Prospective Studies; Renal Insufficiency, Chronic; Renal Replacement Therapy; Smoking; Ultrasonography | 2014 |
Presence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled study.
Topics: Acidosis; Aged; Aged, 80 and over; Anemia; Bicarbonates; Calcium; Case-Control Studies; Creatine; Diabetes Mellitus; Disease Progression; Ethnicity; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Male; New York; Phosphorus; Prognosis; Renal Insufficiency, Chronic; Risk Assessment; Serum Albumin | 2014 |
The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease.
Topics: Adult; Aged; Body Composition; Diet; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Hand Strength; Humans; Hyperkalemia; Middle Aged; Parathyroid Hormone; Phosphorus; Plant Proteins, Dietary; Renal Insufficiency, Chronic; Sodium | 2014 |
High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease.
Topics: Actins; Animals; Aorta; beta Catenin; Blood Urea Nitrogen; Calcium; Cells, Cultured; Core Binding Factor Alpha 1 Subunit; Creatine; Disease Models, Animal; Gene Expression Regulation; Gene Knockdown Techniques; Homeodomain Proteins; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nephrectomy; Osteopontin; Phosphorus; Phosphorus, Dietary; Plasmalogens; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Sodium-Phosphate Cotransporter Proteins, Type III; Vascular Calcification; Wnt Signaling Pathway | 2015 |
Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference.
Topics: Bone Diseases, Metabolic; Calcium; Calcium Chelating Agents; Diphosphonates; Fractures, Bone; Humans; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Vascular Calcification; Vitamin D | 2015 |
Parameters of phosphorus homeostasis at normal and reduced GFR: empiric observations.
Topics: Aged; Aged, 80 and over; Creatinine; Glomerular Filtration Rate; Homeostasis; Humans; Kidney Tubules; Male; Middle Aged; Phosphorus; Renal Insufficiency, Chronic | 2015 |
Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
Topics: Aged; Algorithms; Biomarkers; Calcium; Cross-Sectional Studies; Decision Support Techniques; Dietary Supplements; Female; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Least-Squares Analysis; Linear Models; Male; Middle Aged; Nonlinear Dynamics; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Prognosis; Renal Insufficiency, Chronic; Risk Factors; United States; Vitamin D; Vitamin D Deficiency | 2016 |
Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Asymptomatic Diseases; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Female; Health Status Disparities; Humans; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Phosphorus; Plaque, Atherosclerotic; Predictive Value of Tests; Prognosis; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; Sex Factors; Spain; Ultrasonography; Young Adult | 2015 |
[Bone mineral metabolism in patients with chronic kidney disease on dialysis in Southern Metropolitan Santiago].
Topics: Aged; Bone and Bones; Bone Diseases, Metabolic; Calcium; Chile; Cohort Studies; Female; Guideline Adherence; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Serum Albumin; Time Factors | 2015 |
Renal formulas pretreated with medications alters the nutrient profile.
Topics: Follow-Up Studies; Humans; Hyperkalemia; Hyperphosphatemia; Infant; Infant Formula; Nutritional Support; Phosphorus; Potassium; Renal Insufficiency, Chronic; Sevelamer | 2015 |
Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Predictive Value of Tests; Preoperative Period; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Reproducibility of Results; Retrospective Studies; Risk Factors; Severity of Illness Index | 2015 |
Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study.
Topics: Adult; Aged; C-Reactive Protein; Calcium, Dietary; Cardiovascular Diseases; Creatinine; Cross-Sectional Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Germany; Humans; Iron, Dietary; Linear Models; Male; Middle Aged; Multivariate Analysis; Parathyroid Hormone; Phosphorus; Predictive Value of Tests; Prognosis; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; Sex Factors; Smoking | 2015 |
Urinary phosphorus excretion per creatinine clearance as a prognostic marker for progression of chronic kidney disease: a retrospective cohort study.
Topics: Aged; Cohort Studies; Creatinine; Disease Progression; Female; Humans; Male; Middle Aged; Phosphorus; Prognosis; Renal Insufficiency, Chronic; Retrospective Studies | 2015 |
Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency.
Topics: Administration, Oral; Aged; Aged, 80 and over; Body Weight; Calcifediol; Calcimimetic Agents; Calcitriol; Calcium; Cholecalciferol; Cinacalcet; Drug Dosage Calculations; Drug Substitution; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D Deficiency; Vitamins | 2015 |
Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease.
Topics: Anemia; California; Cohort Studies; Female; Glomerular Filtration Rate; Hemoglobins; Humans; Male; Middle Aged; Odds Ratio; Phosphorus; Renal Insufficiency, Chronic; Risk Factors | 2016 |
Effect of individual health education on hyperphosphatemia in the Hakkas residential area.
Topics: Adult; China; Cross-Sectional Studies; Feeding Behavior; Female; Health Education; Humans; Hyperphosphatemia; Male; Middle Aged; Patient Compliance; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Renal Insufficiency, Chronic; Surveys and Questionnaires | 2015 |
Medical Nutrition Therapy for Chronic Kidney Disease Improves Biomarkers and Slows Time to Dialysis.
Topics: Aged; Biomarkers; Blood Urea Nitrogen; Calcium; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Male; Nutrition Therapy; Nutritionists; Parathyroid Hormone; Phosphorus; Proportional Hazards Models; Quality of Life; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Rural Population; Serum Albumin | 2016 |
Bixalomer, a novel phosphate binder with a small swelling index, improves hyperphosphatemia in chronic kidney disease rat.
Topics: Adsorption; Animals; Hyperphosphatemia; Male; Phosphates; Phosphorus; Polyamines; Rats, Wistar; Renal Insufficiency, Chronic; Water | 2015 |
Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study.
Topics: Aged; Aged, 80 and over; Calcium; Carbon Dioxide; Case-Control Studies; Cholesterol, LDL; Decision Support Systems, Clinical; Female; Glomerular Filtration Rate; Guideline Adherence; Hemoglobins; Humans; Kidney Function Tests; Male; Middle Aged; Nephrology; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Primary Health Care; Proteinuria; Reminder Systems; Renal Insufficiency, Chronic; Transferrins; Vitamin D | 2015 |
[Hyperphosphatemia in Chronic Kidney Disease (CKD)].
Topics: Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperphosphatemia; Kidney; Phosphorus; Renal Insufficiency, Chronic | 2015 |
Dietary phosphorus restriction in predialysis chronic kidney disease: time for a cease-fire?
Topics: Diet; Humans; Kidney Failure, Chronic; Phosphates; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2016 |
Epidemiology and determinants of pruritus in pre-dialysis chronic kidney disease patients.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Calcium; Creatinine; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prevalence; Pruritus; Renal Dialysis; Renal Insufficiency, Chronic; Turkey | 2016 |
Cognitive changes associated with switching to frequent nocturnal hemodialysis or renal transplantation.
Topics: Adult; Attention; Cognition; Creatinine; Dialysis Solutions; Executive Function; Female; Follow-Up Studies; Hemoglobins; Humans; Kidney Transplantation; Longitudinal Studies; Male; Memory; Middle Aged; Neuropsychological Tests; Phosphorus; Psychomotor Performance; Reaction Time; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Verbal Learning | 2016 |
Novel Stratification of Mortality Risk by Kidney Disease Stage.
Topics: Aged; Albumins; Albuminuria; Blood Cell Count; Creatinine; Databases, Factual; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Phosphates; Phosphorus; Proportional Hazards Models; Renal Insufficiency, Chronic; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Treatment Outcome | 2015 |
Genetic African Ancestry and Markers of Mineral Metabolism in CKD.
Topics: Adult; Aged; Biomarkers; Black or African American; Black People; Calcium; Cohort Studies; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Phosphorus; Renal Insufficiency, Chronic; White People; Young Adult | 2016 |
Association between Hemodialysis Patient Outcomes and Compliance with KDOQI and KDIGO Targets for Mineral and Bone Metabolism.
Topics: Adult; Aged; Bone and Bones; Calcium; Female; Goals; Guideline Adherence; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Predictive Value of Tests; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Serbia; Treatment Outcome | 2016 |
Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients.
Topics: Aged; Alkaline Phosphatase; Biomarkers; Calcium; Cause of Death; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; United States | 2016 |
Psychosocial Factors That Create Barriers to Managing Serum Phosphorus Levels in Pediatric Dialysis Patients: A Retrospective Analysis.
Topics: Adolescent; Child; Child, Preschool; Cross-Sectional Studies; Diet; Electronic Health Records; Female; Humans; Hyperphosphatemia; Male; Peritoneal Dialysis; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Socioeconomic Factors | 2016 |
Multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in patients with chronic kidney disease stages 4, 5, and 5D: The OCEANOS study.
Topics: Adult; Africa; Biomarkers; Bone Diseases, Metabolic; Calcium; Chelating Agents; Dietary Supplements; Female; Glomerular Filtration Rate; Guideline Adherence; Humans; Male; Middle Aged; Middle East; Nephrology; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Practice Patterns, Physicians'; Renal Insufficiency, Chronic; Severity of Illness Index; Treatment Outcome; Vitamin D | 2016 |
Abnormal Diurnal Patterns of Parathyroid Hormone are Associated with Sustained Mild Hypercalcemia in Non-Dialyzed Chronic Kidney Disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Calcium; Circadian Rhythm; Female; Fibroblast Growth Factor-23; Glomerular Filtration Rate; Humans; Hypercalcemia; Kidney; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Postprandial Period; Predictive Value of Tests; Prognosis; Renal Insufficiency, Chronic; Severity of Illness Index | 2016 |
Predicting Renal Failure Progression in Chronic Kidney Disease Using Integrated Intelligent Fuzzy Expert System.
Topics: Adult; Aged; Artificial Intelligence; Blood Pressure; Calcium; Creatine; Disease Progression; Expert Systems; Female; Fuzzy Logic; Glomerular Filtration Rate; Humans; Male; Middle Aged; Phosphorus; Renal Insufficiency; Renal Insufficiency, Chronic; Reproducibility of Results; Software; Time Factors | 2016 |
Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.
Topics: Animals; beta Catenin; Biomarkers; Calcification, Physiologic; Calcium; Cathepsin K; Cell Line, Tumor; Core Binding Factor Alpha 1 Subunit; Decalcification, Pathologic; Disease Models, Animal; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Humans; Intercellular Signaling Peptides and Proteins; Klotho Proteins; Male; Membrane Proteins; Osteoblasts; Osteocalcin; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Porosity; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Tibia; Uremia; Wnt Proteins; Wnt Signaling Pathway | 2016 |
Serum phosphorus is related to left ventricular remodeling independent of renal function in hospitalized patients with chronic kidney disease.
Topics: Calcinosis; China; Cross-Sectional Studies; Echocardiography; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Phosphorus; Prevalence; Renal Insufficiency, Chronic; Statistics as Topic; Ventricular Remodeling | 2016 |
The relation of calcium-phosphorus metabolism-related indexes with cardiac damages.
Topics: Calcium; Humans; Myocardium; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic | 2016 |
Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
Topics: Adolescent; Child; Disease Progression; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Transplantation; Male; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Vitamin D | 2016 |
Mineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease: the NEFRONA study.
Topics: Adult; Aged; Atherosclerosis; Blood Pressure; Calcium; Carotid Artery Diseases; Carotid Artery, Common; Carotid Intima-Media Thickness; Cholesterol, HDL; Cholesterol, LDL; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Vitamin D | 2017 |
Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis.
Topics: Aged; Aged, 80 and over; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Off-Label Use; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies; Treatment Outcome | 2016 |
Mineral and Bone Disorder and Its Association with Cardiovascular Parameters in Chinese Patients with Chronic Kidney Disease.
Topics: Adolescent; Adult; Aged; China; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Hypertrophy, Left Ventricular; Logistic Models; Male; Middle Aged; Phosphorus; Prospective Studies; Renal Insufficiency, Chronic; Vascular Calcification; Young Adult | 2016 |
Assessment of dietary intake of children with chronic kidney disease.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Diet; Diet Surveys; Dietary Proteins; Eating; Energy Intake; Female; Glomerular Filtration Rate; Guidelines as Topic; Humans; Infant; Male; Nutritional Requirements; Nutritional Status; Phosphorus; Prospective Studies; Renal Insufficiency, Chronic; Surveys and Questionnaires | 2017 |
Relationship between Anemia and Serum Concentrations of Calcium and Phosphorus in Advanced Non-Dialysis-Dependent Chronic Kidney Disease.
Topics: Aged; Anemia; Biomarkers; Bone Diseases, Metabolic; Calcifediol; Calcium; Cohort Studies; Female; Humans; Male; Middle Aged; Phosphorus; Renal Insufficiency, Chronic | 2017 |
Vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5.
Topics: Adult; Aged; Altitude; Calcitriol; Calcium; Colombia; Cross-Sectional Studies; Ergocalciferols; Female; Humans; Hyperparathyroidism; Male; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Insufficiency, Chronic; Sunlight; Vitamin D; Vitamin D Deficiency | 2016 |
Adenomatous Colon Polyps in Diabetes: Increased Prevalence in Patients with Chronic Kidney Disease and Its Association with Parathyroid Hormone.
Topics: Adenomatous Polyps; Aged; Calcium; Colonic Polyps; Demography; Diabetes Mellitus; Female; Humans; Logistic Models; Male; Multivariate Analysis; Odds Ratio; Parathyroid Hormone; Phosphorus; Prevalence; Probability; Renal Insufficiency, Chronic | 2016 |
Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
Topics: Animals; Calcium; Case-Control Studies; Creatinine; Dog Diseases; Dogs; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Male; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Vitamin D | 2017 |
Hypophosphatemia: nutritional status, body composition, and mortality in hemodialysis patients.
Topics: Aged; Aged, 80 and over; Body Composition; Female; Humans; Hyperphosphatemia; Hypophosphatemia; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Nutritional Status; Phosphorus; Portugal; Prognosis; Proportional Hazards Models; Renal Dialysis; Renal Insufficiency, Chronic; Risk Assessment; Survival Rate | 2017 |
Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
Topics: Animals; Aorta; Blood Flow Velocity; Calcinosis; Calcium; Ergocalciferols; Hyperparathyroidism, Secondary; Male; Nephrectomy; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Renal Insufficiency, Chronic; Uremia; Vascular Resistance | 2008 |
Vitamin D insufficiency and deficiency in children with early chronic kidney disease.
Topics: Adolescent; Calcium; Child; Child, Preschool; Female; Florida; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Infant; Male; Obesity; Overweight; Phosphorus; Renal Insufficiency, Chronic; Vitamin D; Vitamin D Deficiency; Young Adult | 2009 |
Salivary phosphorus binding: a novel approach to control hyperphosphatemia.
Topics: Chewing Gum; Chitosan; Humans; Hyperphosphatemia; Phosphorus; Renal Insufficiency, Chronic; Saliva | 2009 |
Mutant FGF23 prevents the progression of chronic kidney disease but aggravates renal osteodystrophy in uremic rats.
Topics: Animals; Blood Urea Nitrogen; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Creatinine; Disease Progression; Femur; Fibroblast Growth Factors; Kidney; Male; Parathyroid Hormone; Phosphorus; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Uremia | 2009 |
[Hyperparathyroidism in patients on long-term hemodialysis].
Topics: Adult; Calcium; Humans; Hyperparathyroidism, Secondary; Male; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors | 2009 |
Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease.
Topics: Adult; Aged; Alkaline Phosphatase; Black or African American; Calcium; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phosphorus; Proportional Hazards Models; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors | 2009 |
Relationship of sRANKL level and vascular calcification score to cardiovascular events in maintenance hemodialysis patients.
Topics: Adult; Aged; Calcinosis; Cardiovascular Diseases; Cause of Death; Female; Humans; Male; Middle Aged; Phosphorus; RANK Ligand; Regression Analysis; Renal Dialysis; Renal Insufficiency, Chronic; Severity of Illness Index | 2009 |
Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function.
Topics: Adult; Calcinosis; Coronary Artery Disease; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Phosphorus; Prevalence; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; Tomography, X-Ray Computed | 2009 |
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
Topics: Animals; Biomarkers; Bone Resorption; Calcitriol; Calcium; Cinacalcet; Creatinine; Disease Models, Animal; Ergocalciferols; Female; Fibroblast Growth Factors; Hyperparathyroidism; Hyperphosphatemia; Hypocalcemia; Naphthalenes; Nephrectomy; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; Severity of Illness Index; Tibia; Uremia | 2010 |
Efficacy and safety of SBR759, a new iron-based phosphate binder.
Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Phosphates; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Renal Insufficiency, Chronic; Safety; Starch | 2010 |
Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
Topics: Bone Density; Bone Diseases, Metabolic; Calcium; Canada; Disease Management; Fractures, Bone; Nutritional Status; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Renal Insufficiency, Chronic | 2010 |
[Calcium and phosphorus metabolism and cardiovascular disease in chronic kidney disease].
Topics: Calcium; Cardiovascular Diseases; Humans; Phosphorus; Renal Insufficiency, Chronic | 2010 |
Fibroblast growth factor 23 in chronic kidney disease: bridging the gap between bone mineral metabolism and left ventricular hypertrophy.
Topics: Adult; Cross-Sectional Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Phosphorus; Prevalence; Renal Insufficiency, Chronic; Ultrasonography | 2011 |
Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease.
Topics: Adult; Cross-Sectional Studies; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Nutrition Surveys; Phosphorus; Prognosis; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; United States | 2011 |
Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.).
Topics: Algorithms; Biomarkers; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling; Calcinosis; Calciphylaxis; Calcium; Chelation Therapy; Chronic Disease; Combined Modality Therapy; Diagnostic Imaging; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Kidney Transplantation; Minerals; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Receptors, Cell Surface; Reference Values; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D | 2011 |
A mathematical model of calcium and phosphorus metabolism in two forms of hyperparathyroidism.
Topics: Algorithms; Bone and Bones; Calcimimetic Agents; Calcitriol; Calcium; Computer Simulation; Feedback, Physiological; Female; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney; Male; Middle Aged; Models, Biological; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies | 2012 |
Vitamin D deficiency and arterial wall stiffness in children with chronic kidney disease.
Topics: Adolescent; Biomarkers; Calcium; Child; Female; Humans; Male; Phosphorus; Regression Analysis; Renal Insufficiency, Chronic; Vascular Stiffness; Vitamin D; Vitamin D Deficiency | 2012 |
Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antihypertensive Agents; Calcium; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Hypertension, Renal; Iron; Male; Middle Aged; Minerals; Morbidity; Phosphorus; Proteinuria; Renal Insufficiency, Chronic; Severity of Illness Index; Spain; Young Adult | 2011 |
Effectiveness and cost-efficacy of phosphate binders in hemodialysis.
Topics: Adult; Aged; Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cost Savings; Health Care Costs; Hemodialysis Solutions; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Technology Assessment, Biomedical | 2011 |
CKD-mineral and bone disorder: core curriculum 2011.
Topics: Bone Diseases; Calcinosis; Calciphylaxis; Calcitriol; Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Kidney; Kidney Failure, Chronic; Kidney Tubules; Lanthanum; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Vitamin D | 2011 |
Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.
Topics: Animals; Autoantigens; Body Weight; Collagen Type IV; Disease Models, Animal; Disease Progression; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Gene Expression Regulation; Genotype; Humans; Kidney; Longitudinal Studies; Mice; Minerals; Phosphorus; Renal Insufficiency, Chronic; Survival Analysis; Transcription, Genetic | 2012 |
Serum phosphorus as a predictor of low-grade albuminuria in a general population without evidence of chronic kidney disease.
Topics: Adult; Aged; Albuminuria; Biomarkers; Cross-Sectional Studies; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Male; Middle Aged; Phosphorus; Prognosis; Renal Insufficiency, Chronic; Risk Factors | 2012 |
Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD.
Topics: Aged; Black or African American; Calcium; Cohort Studies; Cross-Sectional Studies; Ethnicity; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Phosphorus; Prognosis; Renal Insufficiency, Chronic; Vitamin D | 2012 |
Evidence in favor of a severely impaired net intestinal calcium absorption in patients with (early-stage) chronic kidney disease.
Topics: Adult; Aged; Belgium; Calcifediol; Calcitriol; Calcium, Dietary; Cross-Sectional Studies; Female; Humans; Intestinal Absorption; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic | 2012 |
Relationship of urine dopamine with phosphorus homeostasis in humans: the heart and soul study.
Topics: Aged; Aged, 80 and over; Coronary Disease; Cross-Sectional Studies; Dopamine; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Homeostasis; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2012 |
Jonathan E. Rhoads lecture 2012: improving patient care with practice-based research.
Topics: Brain Injuries; Calcium; Enteral Nutrition; Evidence-Based Medicine; Food-Drug Interactions; Humans; Hypocalcemia; Insulin; Obesity; Pancreatitis; Phosphorus; Renal Insufficiency, Chronic; Research; Treatment Outcome; Warfarin | 2012 |
Relationship between aortic mineral elements and osteodystrophy in mice with chronic kidney disease.
Topics: Animals; Aorta, Thoracic; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Resistance; Early Diagnosis; Hyperparathyroidism, Secondary; Hyperphosphatemia; Magnesium; Male; Mice; Mice, Inbred ICR; Phosphorus; Renal Insufficiency, Chronic; Severity of Illness Index; Spectrophotometry, Atomic; Spectrophotometry, Infrared; Thoracic Vertebrae; Tomography, X-Ray Computed; Vascular Calcification | 2012 |
Classification of chronic kidney disease biomarkers to predict coronary artery calcium.
Topics: Adult; Age Factors; Biomarkers; Calcium; Cohort Studies; Coronary Artery Disease; Coronary Vessels; Female; Glomerular Filtration Rate; Humans; Linear Models; Longitudinal Studies; Male; Middle Aged; Models, Statistical; Phosphorus; Predictive Value of Tests; Renal Insufficiency, Chronic; Risk Factors; Sex Factors; Tomography, X-Ray Computed | 2012 |
Racial differences in parathyroid hormone levels in CKD.
Topics: Black or African American; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Male; Phosphorus; Renal Insufficiency, Chronic; Vitamin D | 2012 |
Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study.
Topics: Aged; Biomarkers; Bone Diseases, Metabolic; Calcimimetic Agents; Calcium; Cinacalcet; Drug Prescriptions; Drug Utilization; Drug Utilization Review; Female; Humans; Hyperparathyroidism, Secondary; Japan; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Patterns, Physicians'; Prevalence; Prospective Studies; Receptors, Calcitriol; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Vitamin D | 2012 |
Renal calcium, phosphorus, magnesium and uric acid handling: comparison between stage III chronic kidney disease patients and healthy oldest old.
Topics: Adult; Aged; Aged, 80 and over; Aging; Calcium; Case-Control Studies; Creatinine; Female; Glomerular Filtration Rate; Humans; Magnesium; Male; Phosphorus; Renal Insufficiency, Chronic; Uric Acid | 2012 |
Fibroblast growth factor 23 (FGF 23) and phosphocalcic metabolism in chronic kidney disease.
Topics: Calcium; Cross-Sectional Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Male; Middle Aged; Phosphorus; Renal Insufficiency, Chronic | 2012 |
Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
Topics: Adult; Aged; Biomarkers; Bone Density; Calcitriol; Cross-Sectional Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic | 2012 |
Pathophysiology of chronic kidney disease-mineral and bone disorder.
Topics: Bone Density; Bone Diseases; Calcium; Comorbidity; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Vitamin D | 2012 |
Correlates of parathyroid hormone concentration in hemodialysis patients.
Topics: Alkaline Phosphatase; Biomarkers; Calcium; Cohort Studies; Female; Humans; Hypercalcemia; Hyperparathyroidism; Hyperphosphatemia; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors | 2013 |
Factors related to nephrotic-range proteinuria in late-stage chronic kidney disease patients with diabetes mellitus.
Topics: Aged; Blood Pressure; Body Mass Index; Creatinine; Cross-Sectional Studies; Diabetic Nephropathies; Female; Humans; Hypertriglyceridemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Proteinuria; Renal Insufficiency, Chronic | 2013 |
The influence of renal function on vitamin D metabolism in the very elderly.
Topics: Aged, 80 and over; Belgium; Calcium; Cholecalciferol; Dietary Supplements; Exercise; Female; Glomerular Filtration Rate; Humans; Kidney; Life Style; Male; Parathyroid Hormone; Phosphorus; Prospective Studies; Reference Values; Renal Insufficiency, Chronic; Seasons; Sex Factors; Sunlight; Vitamin D; Vitamin D Deficiency | 2013 |
Paricalcitol reduces proteinuria but does not modify peritoneal protein loss in patients on peritoneal dialysis.
Topics: Bone Density Conservation Agents; Calcium; Ergocalciferols; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritoneum; Phosphorus; Prospective Studies; Proteins; Proteinuria; Renal Insufficiency, Chronic | 2013 |
Parathyroid enlargement at dialysis initiation in patients with chronic kidney diseases.
Topics: Adult; Aged; Bone Diseases, Metabolic; Calcium; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Ultrasonography | 2013 |
Adherence to phosphate binder therapy is the primary determinant of hyperphosphatemia incidence in patients receiving peritoneal dialysis.
Topics: Adult; Female; Humans; Hyperphosphatemia; Incidence; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Peritoneal Dialysis; Phosphates; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies | 2013 |
Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats.
Topics: Adenine; Animals; Blood Urea Nitrogen; Body Weight; Calcitriol; Calcium; Creatinine; Diet; Eating; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Male; Parathyroid Hormone; Phosphorus; Polyamines; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Sevelamer; Time Factors | 2006 |
Dietary recommendations for obese patients with chronic kidney disease.
Topics: Calcium, Dietary; Diet, Fat-Restricted; Diet, Protein-Restricted; Diet, Sodium-Restricted; Dietary Carbohydrates; Drinking; Energy Intake; Feeding Behavior; Humans; Obesity; Phosphorus; Potassium, Dietary; Renal Insufficiency, Chronic; Vitamin D | 2006 |
[Therapeutic guidelines fulfillment in clinical practice in patients with chronic kidney disease (CKD)].
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Anemia; Calcium; Cross-Sectional Studies; Female; Guideline Adherence; Humans; Hyperlipidemias; Hypertension; Kidney Function Tests; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Spain | 2007 |
Metabolic effects of renal insufficiency in children.
Topics: Anesthesia; Bone and Bones; Calcium; Calcium, Dietary; Child; Humans; Minerals; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 1949 |